Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	SETD1B KMT2B KMT2C KMT2D	7.31e-07	8	205	4	GO:0140945
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	SETD1B KMT2B KMT2C KMT2D	2.16e-06	10	205	4	GO:0140999
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	SETD1B KMT2B KMT2C KMT2D	4.59e-05	20	205	4	GO:0042800
GeneOntologyMolecularFunction	SH2 domain binding	LILRB2 INPPL1 AFAP1L2 KHDRBS1 SIGLEC11	1.91e-04	52	205	5	GO:0042169
GeneOntologyMolecularFunction	molecular adaptor activity	WBP2 ZSWIM8 ARRDC1 BCL9 WNK1 TRIM24 MAPK8IP3 MEN1 KMT2C VAMP2 MAP3K10 BAG6 ZNF541 ABI1 TCF20 HDAC5 AMBRA1 SHANK3 AKAP12 RGS14 KMT2D KHDRBS1 MYH14 HGS STON2 OTUD4 CUX1 MAPK8IP2	3.21e-04	1356	205	28	GO:0060090
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	WBP2 ZSWIM8 ARRDC1 BCL9 WNK1 TRIM24 MAPK8IP3 MEN1 KMT2C VAMP2 MAP3K10 ZNF541 ABI1 TCF20 HDAC5 AMBRA1 SHANK3 AKAP12 RGS14 KMT2D KHDRBS1 HGS STON2 CUX1 MAPK8IP2	3.67e-04	1160	205	25	GO:0030674
GeneOntologyMolecularFunction	signaling adaptor activity	MAPK8IP3 ABI1 SHANK3 AKAP12 RGS14 KHDRBS1 MAPK8IP2	3.77e-04	129	205	7	GO:0035591
GeneOntologyMolecularFunction	SH3 domain binding	INPPL1 AFAP1L2 ABI1 ARHGAP17 SHANK3 KHDRBS1 WASF2	6.99e-04	143	205	7	GO:0017124
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RIN3 TBC1D2B EPS8L1 DENND1C GMIP RIC8A PLXNB1 RANGAP1 ARHGAP17 PLEKHG2 RGS3 RGS14 ARHGEF40 RGL4	7.86e-04	507	205	14	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RIN3 TBC1D2B EPS8L1 DENND1C GMIP RIC8A PLXNB1 RANGAP1 ARHGAP17 PLEKHG2 RGS3 RGS14 ARHGEF40 RGL4	7.86e-04	507	205	14	GO:0030695
GeneOntologyMolecularFunction	GTPase activating protein binding	FMNL1 PLXNB1 RGS14	9.15e-04	19	205	3	GO:0032794
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	WBP2 SCRT1 SALL3 ZNF395 HNF4A TRIM24 HNF4G MEOX2 WIZ GLI1 KLF5 ZNF358 TET3 TBX5 CUX2 HDAC5 ZBTB4 SALL4 HIVEP3 FOXP4 ZFHX2 DMRTC2 SIX5 ELF4 CUX1	1.01e-03	1244	205	25	GO:0000978
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	SETD1B KMT2B KMT2C KMT2D	1.06e-03	44	205	4	GO:0140938
GeneOntologyCellularComponent	histone methyltransferase complex	SETD1B KMT2B MEN1 PHF1 KMT2C KMT2D	1.00e-04	75	207	6	GO:0035097
Domain	FYrich_C	KMT2B KMT2C KMT2D	1.16e-05	5	198	3	IPR003889
Domain	FYrich_N	KMT2B KMT2C KMT2D	1.16e-05	5	198	3	IPR003888
Domain	FYRC	KMT2B KMT2C KMT2D	1.16e-05	5	198	3	SM00542
Domain	FYRN	KMT2B KMT2C KMT2D	1.16e-05	5	198	3	SM00541
Domain	FYRN	KMT2B KMT2C KMT2D	1.16e-05	5	198	3	PF05964
Domain	FYRC	KMT2B KMT2C KMT2D	1.16e-05	5	198	3	PF05965
Domain	FYRC	KMT2B KMT2C KMT2D	1.16e-05	5	198	3	PS51543
Domain	FYRN	KMT2B KMT2C KMT2D	1.16e-05	5	198	3	PS51542
Domain	Post-SET_dom	SETD1B KMT2B KMT2C KMT2D	2.02e-05	16	198	4	IPR003616
Domain	PostSET	SETD1B KMT2B KMT2C KMT2D	2.02e-05	16	198	4	SM00508
Domain	POST_SET	SETD1B KMT2B KMT2C KMT2D	2.02e-05	16	198	4	PS50868
Domain	Znf_FYVE_PHD	KMT2B FYCO1 TRIM24 PHF1 KMT2C TCF20 ZBTB4 KMT2D HGS	2.75e-05	147	198	9	IPR011011
Domain	EPHD	KMT2B KMT2C TCF20 KMT2D	7.72e-05	22	198	4	PS51805
Domain	PHD	KMT2B TRIM24 PHF1 KMT2C TCF20 KMT2D	3.68e-04	89	198	6	SM00249
Domain	Znf_PHD	KMT2B TRIM24 PHF1 KMT2C TCF20 KMT2D	4.15e-04	91	198	6	IPR001965
Domain	ZF_PHD_2	KMT2B TRIM24 PHF1 KMT2C TCF20 KMT2D	5.23e-04	95	198	6	PS50016
Domain	ZF_PHD_1	KMT2B TRIM24 PHF1 KMT2C TCF20 KMT2D	5.53e-04	96	198	6	PS01359
Domain	C1	GMIP KMT2C PDZD8 TNS2 PRKCZ	6.28e-04	65	198	5	SM00109
Domain	PE/DAG-bd	GMIP KMT2C PDZD8 TNS2 PRKCZ	6.74e-04	66	198	5	IPR002219
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 TRNP1 RIN3 ABCA2 ANKS6 SETD1B KMT2B INPPL1 C15orf39 FYCO1 ANKLE1 ZNF395 BCL9 TTC3 WNK1 PRAG1 CIC CASZ1 MAPK8IP3 KMT2C URB1 PHLDB1 EHBP1L1 WIZ TMEM259 GLI1 NBEAL2 PDZD8 RIC8A WNK2 BAHCC1 HSPG2 RTL6 CTC1 ZBTB4 ARHGAP17 AMBRA1 EML3 C6orf132 HIVEP3 ARHGEF40 KMT2D PWWP2B ADAMTS7 TMEM268 TNKS1BP1 MAPKBP1 PRRT4	2.95e-27	1105	211	48	35748872
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	VWA5B2 C15orf39 NACAD CASZ1 KMT2C TET3 WNK2 TCF20 FRAT1 MAGEE1 RGS3 SHANK3 AKAP12 SIX5 LBX2 MAPK8IP2	1.27e-12	233	211	16	37704626
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ATXN2L ZSWIM8 KMT2B WNK1 SSPOP CIC MEOX2 AFAP1L2 POM121 RIC8A BAG6 WNK2 HSPG2 TNS2 MAGEE1 MYH14 HGS SIX5 MAPKBP1	7.09e-09	608	211	19	16713569
Pubmed	Alternative splice variants encoding unstable protein domains exist in the human brain.	ABCA2 PHLDB1 NRXN2 HDAC5 MAPKBP1	9.70e-09	13	211	5	15491607
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	WBP2 INPPL1 TSC22D2 BCL9 WNK1 CIC ZNF469 POM121 KLF5 WNK2 CUX2 HDAC5 MAGEE1 C6orf132 UBQLN3 STON2	1.03e-08	430	211	16	35044719
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ANKS6 TSC1 CDHR5 PHLDB1 EHBP1L1 AFAP1L2 PTPRJ CASKIN2 NBEAL2 VAMP2 PLXNB1 ABI1 CARMIL2 MINK1 SMPD4 RAB11FIP1 WASF2 STON2	1.49e-08	569	211	18	30639242
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TSC1 FYCO1 BCL9 TTC3 MAPK8IP3 WIZ AP1B1 TMEM259 DIAPH1 GOLGA3 WNK2 FKBP15 RANGAP1 ABI1 TCF20 MINK1 SHANK3 AKAP12 WASF2 STON2 OTUD4 CUX1 MAPK8IP2	2.68e-08	963	211	23	28671696
Pubmed	A human MAP kinase interactome.	SETX WNK1 CIC KMT2C POM121 MAP3K10 WNK2 TCF20 ARHGAP17 PTPN23 NCKAP5L KHDRBS1 HGS PRKCZ WASH2P CUX1	5.63e-08	486	211	16	20936779
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ATXN2L SF3B4 SETX INPPL1 WNK1 PRAG1 CIC PHLDB1 CASKIN2 MAP3K10 NHS ABI1 CARMIL2 TCF20 MINK1 ARHGAP17 PLEKHG2 RAB11FIP1 NCKAP5L C6orf132 TNKS1BP1	7.89e-08	861	211	21	36931259
Pubmed	The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.	SETD1B KMT2B KMT2C KMT2D	9.04e-08	8	211	4	22266653
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	SETD1B KMT2B KMT2C KMT2D	9.04e-08	8	211	4	23130995
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	BCL7C BCL9 TRIM24 CIC CASZ1 WIZ KLF5 TCF20 FOXP4 KMT2D PRPF3 CUX1	1.04e-07	268	211	12	33640491
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	SF3B4 TSC1 CIC CACTIN WIZ PTPRJ CASKIN2 VAMP2 PDZD8 NHS UNG RANGAP1 MINK1 DUSP8 PTPN23 TNS2 SMPD4 RAB11FIP1 NCKAP5L KMT2D PRPF3 HGS OTUD4	1.24e-07	1049	211	23	27880917
Pubmed	Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.	SETD1B KMT2B KMT2C KMT2D	1.62e-07	9	211	4	22665483
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	SETD1B KMT2B MEN1 KMT2C KMT2D	1.90e-07	22	211	5	26886794
Pubmed	A census of human transcription factors: function, expression and evolution.	ZNF395 TSC22D2 HNF4A HNF4G CIC MEOX2 GLI1 KLF5 ZNF541 TBX5 CUX2 ZBTB4 ZNF385A HIVEP3 FOXP4 KMT2D ZFHX2 DMRTC2 SIX5 ELF4 LBX2	1.90e-07	908	211	21	19274049
Pubmed	Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.	SETD1B KMT2B MEN1 KMT2C FMNL1 KMT2D	5.91e-07	50	211	6	37974198
Pubmed	Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.	SETD1B KMT2B KMT2C KMT2D	6.27e-07	12	211	4	27563068
Pubmed	Rebalancing gene haploinsufficiency in vivo by targeting chromatin.	KMT2B KMT2C TBX5 SALL4 PRKCZ	6.88e-07	28	211	5	27256596
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ATXN2L ZSWIM8 SETX SETD1B INPPL1 TBC1D2B C15orf39 TSC1 WNK1 CIC DIAPH1 HDAC5 ARHGAP17 NCKAP5L POLR3C TNKS1BP1	7.22e-07	588	211	16	38580884
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	BCL9 TRIM24 CIC WIZ TCF20 KMT2D CUX1	7.69e-07	83	211	7	28794006
Pubmed	Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation.	KMT2B KMT2C KMT2D	8.77e-07	4	211	3	19221051
Pubmed	A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.	KMT2B KMT2C KMT2D	8.77e-07	4	211	3	23129768
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	C15orf39 TRIM24 CASZ1 KMT2C WIZ DIAPH1 BAHCC1 TCF20 NCKAP5L FOXP4 KMT2D SIX5 CUX1	1.12e-06	398	211	13	35016035
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L KMT2B BCL7C BCL9 CIC USP19 MAPK8IP3 CACTIN UNG MN1 BAG6 RANGAP1 TCF20 MINK1 KMT2D PWWP2B OTUD4 TNKS1BP1	1.37e-06	774	211	18	15302935
Pubmed	Interaction network of human early embryonic transcription factors.	KMT2B BCL7C C15orf39 BCL9 TRIM24 KMT2C WIZ BAHCC1 TCF20 HDAC5 FOXP4 KMT2D	1.82e-06	351	211	12	38297188
Pubmed	MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.	KMT2B MEN1 KMT2D	2.18e-06	5	211	3	28609655
Pubmed	H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.	SETD1B KMT2B KMT2C KMT2D	2.26e-06	16	211	4	24368734
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	SALL3 KMT2B MEN1 KMT2C WIZ KLF5 RANGAP1 SALL4	3.31e-06	146	211	8	23892456
Pubmed	Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ABCA2 SETD1B TBC1D2B MAPK8IP3 TNS2 OTUD4 ZFHX2	3.53e-06	104	211	7	10470851
Pubmed	PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.	KMT2B MEN1 KMT2C KMT2D	3.77e-06	18	211	4	17500065
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	SF3B4 ADGRB1 PHLDB1 EHBP1L1 AFAP1L2 PTPRJ CASKIN2 VAMP2 NIBAN1 MINK1 AKAP12 WASF2	3.79e-06	377	211	12	38117590
Pubmed	MLL associates specifically with a subset of transcriptionally active target genes.	KMT2B MEN1 KMT2D	4.34e-06	6	211	3	16199523
Pubmed	Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases.	KMT2B KMT2C KMT2D	4.34e-06	6	211	3	17021013
Pubmed	Characterization of three growth hormone-responsive transcription factors preferentially expressed in adult female liver.	HNF4A TRIM24 CUX2	4.34e-06	6	211	3	17412818
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	URB1 DIAPH1 GOLGA3 FKBP15 SMC4 PTPN23 ARHGEF40 KHDRBS1 MYH14	4.40e-06	202	211	9	24639526
Pubmed	WW domains provide a platform for the assembly of multiprotein networks.	WBP2 SF3B4 DIAPH1 FMNL1 ABI1 KHDRBS1 PRPF3 WASF2	4.91e-06	154	211	8	16055720
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ABCA2 SETX TBC1D2B NACAD KMT2C NRXN2 CASKIN2 NBEAL2 WNK2 PLXNB1 RANGAP1 AMBRA1 SMPD4 TNKS1BP1	4.99e-06	529	211	14	14621295
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	SETX TRIM24 CIC CASZ1 MEN1 CRACD WIZ GLI1 RANGAP1 ABI1 HDAC5 SMC4 SMPD4 FOXP4 KMT2D WASF2 SIX5 CUX1	5.63e-06	857	211	18	25609649
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SETX BCL7C NOL6 ZNF831 PHF1 KMT2C CACTIN BAG6 HDAC5 SMC4 SALL4 KMT2D TNKS1BP1	6.68e-06	469	211	13	27634302
Pubmed	Structural insights into trans-histone regulation of H3K4 methylation by unique histone H4 binding of MLL3/4.	KMT2B KMT2C KMT2D	7.57e-06	7	211	3	30604749
Pubmed	ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.	KMT2B KMT2C KMT2D	7.57e-06	7	211	3	19556342
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	HNF4A HNF4G CIC MEOX2 PHF1 KMT2C GLI1 KLF5 ZNF358 CUX2 TCF20 FOXP4 ZFHX2 SIX5 LBX2 CUX1	7.85e-06	709	211	16	22988430
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ATXN2L NOL6 WDR46 MEN1 WIZ RANGAP1 TCF20 SMC4 KMT2D KHDRBS1 TNKS1BP1	8.52e-06	341	211	11	32971831
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	SALL3 KMT2C WIZ KLF5 FKBP15 SALL4 FOXP4 KMT2D	8.91e-06	167	211	8	20362541
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ATXN2L INPPL1 EPS8L1 EHBP1L1 PTPRJ CASKIN2 NHS GOLGA3 RANGAP1 ABI1 MINK1 C6orf132 WASF2 TNKS1BP1	1.05e-05	565	211	14	25468996
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	WNK1 KMT2C URB1 PHLDB1 NRXN2 CUX2 HDAC5 PTPN23 TNKS1BP1	1.05e-05	225	211	9	12168954
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	KMT2B RUSC1 C15orf39 TRIM24 CIC WIZ GOLGA3 TCF20 HDAC5 KMT2D TNKS1BP1 CUX1	1.07e-05	418	211	12	34709266
Pubmed	Prediction of the coding sequences of mouse homologues of FLJ genes: the complete nucleotide sequences of 110 mouse FLJ-homologous cDnas identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	VSIR TMEM259 FMNL1 PLEKHG2 RAB11FIP1 ARHGEF40	1.36e-05	85	211	6	15449545
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ATXN2L SETX KMT2B C15orf39 BCL9 TRIM24 CIC KMT2C WIZ AP1B1 KLF5 UNG BAG6 TCF20 SMC4 UBXN1 KMT2D KHDRBS1 PRPF3 CUX1	1.46e-05	1103	211	20	34189442
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	ATXN2L WNK1 CRACD BAG6 WNK2 SMC4 SOWAHA MYH14 OTUD4	1.49e-05	235	211	9	30258100
Pubmed	Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans.	CIC CUX2 SHANK3 CUX1	1.51e-05	25	211	4	28288114
Pubmed	High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.	INPPL1 CDHR5 WNK1 VSIR TMUB1 EHBP1L1 PTPRJ TMEM259 KLF5 NHS RANGAP1 TCF20 OGFR TNS2 FAM156A YBX2 TNKS1BP1 WASH2P MAPKBP1	1.68e-05	1021	211	19	26760575
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	ZSWIM8 ANKS6 ARRDC1 INPPL1 TBC1D2B C15orf39 FYCO1 GMIP WNK1 DNAAF3 PHLDB1 AP1B1 KLF5 FKBP15 HDAC5 RAB11FIP1 NCKAP5L OTUD4 TNKS1BP1	2.11e-05	1038	211	19	26673895
Pubmed	A Hypoxia-Induced SCFFBXL1 E3 Ligase Ubiquitinates and Degrades the MEN1 Tumor Suppressor to Promote Colorectal Cancer Tumorigenesis.	NOL6 MEN1 AMBRA1 UBXN1 CUX1	2.13e-05	55	211	5	34237211
Pubmed	Human transcription factor protein interaction networks.	KMT2B BCL7C C15orf39 BCL9 HNF4A TRIM24 CIC KMT2C WIZ KLF5 HSPG2 TCF20 HDAC5 DHX37 FOXP4 KMT2D KHDRBS1 MYH14 HGS OTUD4 SIX5 ELF4 CUX1	2.17e-05	1429	211	23	35140242
Pubmed	The AERO system: a 3D-like approach for recording gene expression patterns in the whole mouse embryo.	SALL3 MEOX2 GLI1 SALL4 ZNF385A FOXP4 KHDRBS1 DMRTC2	2.36e-05	191	211	8	24146773
Pubmed	Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.	COL4A6 HSPG2 CD93	2.56e-05	10	211	3	9136074
Pubmed	Endofin is required for HD-PTP and ESCRT-0 interdependent endosomal sorting of ubiquitinated transmembrane cargoes.	INPPL1 WNK1 FKBP15 PTPN23 HGS	3.26e-05	60	211	5	34761192
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	HNF4A HNF4G CIC MEOX2 FOXP4 ZFHX2 SIX5 ELF4 LBX2	3.60e-05	263	211	9	20932939
Pubmed	Identification and characterization of a novel human PP1 phosphatase complex.	SETD1B KMT2B KMT2C KMT2D	3.64e-05	31	211	4	20516061
Pubmed	Cux1 and Cux2 selectively target basal and apical dendritic compartments of layer II-III cortical neurons.	CUX2 CUX1	3.66e-05	2	211	2	25059644
Pubmed	MLL4 binds TET3.	KMT2B TET3	3.66e-05	2	211	2	38579707
Pubmed	Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids.	HNF4A HNF4G	3.66e-05	2	211	2	12220494
Pubmed	Menin directly represses Gli1 expression independent of canonical Hedgehog signaling.	MEN1 GLI1	3.66e-05	2	211	2	23928057
Pubmed	CUX2 deficiency causes facilitation of excitatory synaptic transmission onto hippocampus and increased seizure susceptibility to kainate.	CUX2 CUX1	3.66e-05	2	211	2	35581205
Pubmed	Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes.	HNF4A HNF4G	3.66e-05	2	211	2	8622695
Pubmed	Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4).	KMT2B KMT2D	3.66e-05	2	211	2	35640156
Pubmed	KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.	KMT2C KMT2D	3.66e-05	2	211	2	31924266
Pubmed	Deafness and loss of cochlear hair cells in the absence of thyroid hormone transporters Slc16a2 (Mct8) and Slc16a10 (Mct10).	SLC16A2 SLC16A10	3.66e-05	2	211	2	29535325
Pubmed	The Differential Effect of a Shortage of Thyroid Hormone Compared with Knockout of Thyroid Hormone Transporters Mct8 and Mct10 on Murine Macrophage Polarization.	SLC16A2 SLC16A10	3.66e-05	2	211	2	38396788
Pubmed	Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.	KMT2C KMT2D	3.66e-05	2	211	2	28967912
Pubmed	Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction.	SLC16A2 SLC16A10	3.66e-05	2	211	2	20167367
Pubmed	Induction of Hepatic Metabolic Functions by a Novel Variant of Hepatocyte Nuclear Factor 4γ.	HNF4A HNF4G	3.66e-05	2	211	2	30224520
Pubmed	Glucose Tolerance Is Improved in Mice Invalidated for the Nuclear Receptor HNF-4γ: A Critical Role for Enteroendocrine Cell Lineage.	HNF4A HNF4G	3.66e-05	2	211	2	25829452
Pubmed	Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.	KMT2C KMT2D	3.66e-05	2	211	2	36601880
Pubmed	WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia.	WNK1 WNK2	3.66e-05	2	211	2	35849656
Pubmed	Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.	KMT2C KMT2D	3.66e-05	2	211	2	28483418
Pubmed	Cux-1 and Cux-2 control the development of Reelin expressing cortical interneurons.	CUX2 CUX1	3.66e-05	2	211	2	18327765
Pubmed	Three-dimensional interactions between enhancers and promoters during intestinal differentiation depend upon HNF4.	HNF4A HNF4G	3.66e-05	2	211	2	33503426
Pubmed	Intestine-specific ablation of the Hepatocyte Nuclear Factor 4a (Hnf4a) gene in mice has minimal impact on serum lipids and ileum gene expression profile due to upregulation of its paralog Hnf4g.	HNF4A HNF4G	3.66e-05	2	211	2	34973414
Pubmed	The thyroid hormone transporters MCT8 and MCT10 transport the affinity-label N-bromoacetyl-[(125)I]T3 but are not modified by it.	SLC16A2 SLC16A10	3.66e-05	2	211	2	21315799
Pubmed	A unique variant of a homeobox gene related to Drosophila cut is expressed in mouse testis.	CUX2 CUX1	3.66e-05	2	211	2	8879483
Pubmed	Proteomic analysis of native hepatocyte nuclear factor-4α (HNF4α) isoforms, phosphorylation status, and interactive cofactors.	HNF4A HNF4G	3.66e-05	2	211	2	21047794
Pubmed	Autoinhibition regulates cellular localization and actin assembly activity of the diaphanous-related formins FRLalpha and mDia1.	DIAPH1 FMNL1	3.66e-05	2	211	2	16943183
Pubmed	The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.	KMT2C KMT2D	3.66e-05	2	211	2	34156443
Pubmed	Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10.	SLC16A2 SLC16A10	3.66e-05	2	211	2	18337592
Pubmed	Organization of a cytoskeletal superstructure in the apical domain of intestinal tuft cells.	CDHR5 MYH14	3.66e-05	2	211	2	39352498
Pubmed	Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model.	TSC1 GLI1	3.66e-05	2	211	2	30134066
Pubmed	Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.	KMT2C KMT2D	3.66e-05	2	211	2	27280393
Pubmed	Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion.	SHANK3 MAPK8IP2	3.66e-05	2	211	2	23225497
Pubmed	Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.	KMT2C KMT2D	3.66e-05	2	211	2	36869380
Pubmed	A WAVE2-Abi1 complex mediates CSF-1-induced F-actin-rich membrane protrusions and migration in macrophages.	ABI1 WASF2	3.66e-05	2	211	2	16280551
Pubmed	Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders.	KMT2B KMT2D	3.66e-05	2	211	2	35506254
Pubmed	Expression of a cut-related homeobox gene in developing and polycystic mouse kidney.	CUX2 CUX1	3.66e-05	2	211	2	8840273
Pubmed	Serum kisspeptin levels correlated with anti-mullerian hormone levels in women with and without polycystic ovarian syndrome.	KISS1 AMH	3.66e-05	2	211	2	32964765
Pubmed	Tissue-specific alterations in thyroid hormone homeostasis in combined Mct10 and Mct8 deficiency.	SLC16A2 SLC16A10	3.66e-05	2	211	2	24248460
Pubmed	Cux1 Enables Interhemispheric Connections of Layer II/III Neurons by Regulating Kv1-Dependent Firing.	CUX2 CUX1	3.66e-05	2	211	2	26804994
Pubmed	Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice.	KMT2C KMT2D	3.66e-05	2	211	2	25346535
Pubmed	The Wave complex controls epidermal morphogenesis and proliferation by suppressing Wnt-Sox9 signaling.	ABI1 WASF2	3.66e-05	2	211	2	30867227
Interaction	TOP3B interactions	VWA5B2 TRNP1 RIN3 ABCA2 ANKS6 SETD1B KMT2B INPPL1 C15orf39 FYCO1 ANKLE1 ZNF395 BCL9 TTC3 WNK1 PRAG1 CIC CASZ1 MAPK8IP3 KMT2C URB1 PHLDB1 EHBP1L1 WIZ TMEM259 GLI1 NBEAL2 PDZD8 RIC8A WNK2 BAHCC1 HSPG2 RTL6 CTC1 ZBTB4 ARHGAP17 AMBRA1 EML3 C6orf132 HIVEP3 ARHGEF40 KMT2D PWWP2B ADAMTS7 TMEM268 OTUD4 TNKS1BP1 MAPKBP1 PRRT4	1.63e-13	1470	209	49	int:TOP3B
Interaction	SOX7 interactions	C15orf39 TRIM24 CASZ1 KMT2C WIZ BAHCC1 TCF20 FOXP4 KMT2D	1.78e-07	82	209	9	int:SOX7
Interaction	YWHAH interactions	ATXN2L RIN3 ABCA2 SETX INPPL1 TSC1 ZNF395 WNK1 PRAG1 CIC PHLDB1 CASKIN2 MAP3K10 NHS WNK2 ABI1 CARMIL2 TCF20 HDAC5 MINK1 ARHGAP17 TNS2 PLEKHG2 RAB11FIP1 NCKAP5L EML3 C6orf132 WASF2 TNKS1BP1 PRKCZ	1.25e-06	1102	209	30	int:YWHAH
Interaction	FEV interactions	KMT2B C15orf39 BCL9 TRIM24 CIC KMT2C WIZ TCF20 FOXP4 KMT2D SIX5 CUX1	1.46e-06	203	209	12	int:FEV
Interaction	PAX6 interactions	BCL7C FYCO1 BCL9 TTC3 TRIM24 CIC KMT2C WIZ PSORS1C2 DIAPH1 RGS3 SHANK3 POLR3C KMT2D HGS CUX1	1.48e-06	366	209	16	int:PAX6
Interaction	TBXT interactions	BCL7C BCL9 TRIM24 CIC KMT2C WIZ TCF20 KMT2D CUX1	3.41e-06	116	209	9	int:TBXT
Interaction	ATN1 interactions	ZSWIM8 SETD1B KMT2B TSC1 SSPOP MEN1 KMT2C BAG6 HSPG2 SHANK3 HGS	4.24e-06	187	209	11	int:ATN1
Interaction	FOXI1 interactions	BCL7C BCL9 TRIM24 KMT2C SMPD4 FOXP4 KMT2D HGS	5.16e-06	92	209	8	int:FOXI1
Interaction	RAC1 interactions	INPPL1 TBC1D2B TSC1 GMIP EHBP1L1 AP1B1 PTPRJ CASKIN2 VAMP2 DIAPH1 MAP3K10 PDZD8 NHS BAG6 FMNL1 PLXNB1 ABI1 CARMIL2 MINK1 ARHGAP17 PLEKHG2 RAB11FIP1 NCKAP5L SHANK3 AKAP12 ARHGEF40 WASF2 STON2	5.48e-06	1063	209	28	int:RAC1
Interaction	SOX17 interactions	BCL9 TRIM24 CIC KMT2C WIZ TCF20 FOXP4 KMT2D	6.57e-06	95	209	8	int:SOX17
Interaction	FOXL1 interactions	BCL9 CIC KMT2C RANGAP1 SMC4 SMPD4 FOXP4 KMT2D MYH14 SIX5 CUX1	6.65e-06	196	209	11	int:FOXL1
Interaction	KDM6A interactions	SETD1B KMT2B HNF4A MEN1 MEOX2 KMT2C KLF5 TBX5 KMT2D ELF4	7.63e-06	162	209	10	int:KDM6A
Interaction	KANSL2 interactions	SETD1B KMT2B TSC1 TTC3 HNF4A MEN1 ELF4	8.04e-06	70	209	7	int:KANSL2
Interaction	BAIAP2 interactions	SF3B4 ADGRB1 EPS8L1 DIAPH1 TBX5 ABI1 RAB11FIP1 SHANK3 C6orf132 RGS14 WASF2	8.45e-06	201	209	11	int:BAIAP2
Interaction	ABI2 interactions	RUSC1 EPS8L1 MEOX2 PHF1 CASKIN2 NHS ABI1 WASHC1 SHANK3 PWWP2B KHDRBS1 WASF2 HGS	9.65e-06	286	209	13	int:ABI2
Interaction	CXXC1 interactions	SETD1B KMT2B HNF4A MEN1 MEOX2 KMT2C TET3 KMT2D ELF4	9.85e-06	132	209	9	int:CXXC1
Interaction	CRX interactions	BCL7C C15orf39 BCL9 TRIM24 KMT2C WIZ BAHCC1 TCF20 TNS2 FOXP4 KMT2D HGS	1.46e-05	254	209	12	int:CRX
Interaction	HOMER3 interactions	WBP2 TSC1 POM121 PSORS1C2 ABI1 HDAC5 ZBTB4 SHANK3 WASF2	1.58e-05	140	209	9	int:HOMER3
Interaction	TLX2 interactions	BCL9 CIC KMT2C WIZ TCF20 DHX37 FOXP4 KMT2D CUX1	1.77e-05	142	209	9	int:TLX2
Interaction	SP7 interactions	KMT2B BCL7C C15orf39 BCL9 TRIM24 CIC KMT2C WIZ TCF20 FOXP4 KMT2D KHDRBS1 CUX1	1.84e-05	304	209	13	int:SP7
Interaction	LHX3 interactions	BCL9 TRIM24 CIC KMT2C GLI1 PSORS1C2 TCF20 FOXP4 KMT2D CUX1	2.43e-05	185	209	10	int:LHX3
Interaction	WNK3 interactions	TSC1 TSC22D2 WNK1 AP1B1 WNK2 STON2	2.44e-05	56	209	6	int:WNK3
Interaction	KANSL3 interactions	SETD1B KMT2B USP9Y HNF4A MEN1 KMT2C ELF4	3.13e-05	86	209	7	int:KANSL3
Interaction	GAS7 interactions	DIAPH1 FMNL1 ABI1 KHDRBS1 WASF2	4.34e-05	38	209	5	int:GAS7
Interaction	LHX4 interactions	BCL7C BCL9 TRIM24 CIC KMT2C ABI1 FOXP4 KMT2D WASF2	6.07e-05	166	209	9	int:LHX4
Interaction	SOX9 interactions	BCL7C BCL9 CIC KMT2C HDAC5 KMT2D CUX1	6.81e-05	97	209	7	int:SOX9
Interaction	EGR2 interactions	C15orf39 BCL9 TRIM24 KMT2C WIZ BAHCC1 HDAC5 FOXP4 KMT2D	7.63e-05	171	209	9	int:EGR2
Interaction	PFN1 interactions	INPPL1 TBC1D2B TSC1 WNK1 TRIM24 DIAPH1 FMNL1 GOLGA3 ZNF541 ABI1 HDAC5 ARHGAP17 C6orf132 WASF2 TNKS1BP1 PRKCZ	8.69e-05	509	209	16	int:PFN1
Interaction	TLX1 interactions	BCL7C BCL9 CIC KMT2C WIZ TCF20 FOXP4 KMT2D CUX1	9.12e-05	175	209	9	int:TLX1
Interaction	LURAP1 interactions	SETX TBC1D2B TSC1 TSPYL1 TTC3 TRIM24 FKBP15 HGS	9.32e-05	137	209	8	int:LURAP1
Interaction	LHX1 interactions	BCL7C BCL9 TRIM24 KMT2C WIZ FOXP4 KMT2D	9.96e-05	103	209	7	int:LHX1
Interaction	TRA interactions	USP19 TMUB1 BAG6 UBXN1	1.01e-04	24	209	4	int:TRA
Interaction	EEF1AKMT3 interactions	ZSWIM8 SETX TBC1D2B TSPYL1 WNK1 EHBP1L1 NBEAL2 PDZD8 BAG6 WNK2 SMC4 UBXN1 FOXP4	1.16e-04	364	209	13	int:EEF1AKMT3
Interaction	NFIB interactions	BCL7C BCL9 HNF4A CIC MEN1 KMT2C FOXP4 KMT2D	1.20e-04	142	209	8	int:NFIB
Interaction	CTAGE1 interactions	CTAGE6 CTAGE8 CTAGE15	1.25e-04	10	209	3	int:CTAGE1
Interaction	ZNF148 interactions	IL16 INPPL1 HNF4A CIC MEN1 KLF5 FOXP4 ELF4	1.32e-04	144	209	8	int:ZNF148
Interaction	KCNJ10 interactions	IL16 TMUB1 PDZD8 SHANK3 RGS14	1.36e-04	48	209	5	int:KCNJ10
Interaction	NCOA6 interactions	SETD1B KMT2B HNF4A MEN1 KMT2C KLF5 RANGAP1 KMT2D	1.38e-04	145	209	8	int:NCOA6
Interaction	TRIP10 interactions	MEN1 MEOX2 AP1B1 BAG6 ABI1 ARHGAP17 SHANK3	1.42e-04	109	209	7	int:TRIP10
Interaction	RFXANK interactions	SETX TBC1D2B HNF4A USP19 BAG6 HDAC5 SMC4 FOXP4	1.45e-04	146	209	8	int:RFXANK
Interaction	PAX8 interactions	WBP2 BCL7C BCL9 CIC KMT2C FOXP4 KMT2D	1.59e-04	111	209	7	int:PAX8
Interaction	TLE3 interactions	C15orf39 BCL9 CIC MEN1 CACTIN POM121 KLF5 TCF20 ZBTB4 KMT2D OTUD4 TNKS1BP1 CUX1	1.60e-04	376	209	13	int:TLE3
Interaction	ATXN1 interactions	ATXN2L ZSWIM8 KMT2B TSC1 HNF4A WNK1 CIC ZBP1 POM121 AP1B1 KLF5 DIAPH1 BAG6 WNK2 RANGAP1 ABI1 DHX37 PTPN23 UBXN1 EML3 AKAP12 SIX5 ELF4 CDRT15P3	2.06e-04	1039	209	24	int:ATXN1
Interaction	SPATA12 interactions	RIN3 TNS2 HGS	2.26e-04	12	209	3	int:SPATA12
Interaction	YWHAG interactions	ATXN2L SF3B4 TSC1 ZNF395 WNK1 PRAG1 CIC CRACD PHLDB1 TTBK1 CASKIN2 MAP3K10 NHS ABI1 CARMIL2 HDAC5 MINK1 ARHGAP17 TNS2 PLEKHG2 RAB11FIP1 NCKAP5L EML3 SHANK3 C6orf132 WASF2 PRKCZ	2.35e-04	1248	209	27	int:YWHAG
Interaction	GATA2 interactions	BCL7C BCL9 TRIM24 CIC KMT2C WIZ HDAC5 KMT2D CUX1	2.40e-04	199	209	9	int:GATA2
Interaction	TLX3 interactions	C15orf39 BCL9 TRIM24 HNF4G CIC KMT2C WIZ TCF20 FOXP4 KMT2D CUX1	2.40e-04	291	209	11	int:TLX3
Interaction	VASP interactions	WBP2 INPPL1 TBC1D2B PSORS1C2 DIAPH1 NHS ABI1 PTPN23 C6orf132 WASF2 TNKS1BP1	2.62e-04	294	209	11	int:VASP
Interaction	FXR1 interactions	ATXN2L RIN3 TSC1 FYCO1 TTC3 MAPK8IP3 MEN1 PHLDB1 GLI1 GOLGA3 RANGAP1 ABI1 HDAC5 SHANK3 KHDRBS1 STON2 OTUD4 MAPKBP1	2.66e-04	679	209	18	int:FXR1
Interaction	SPATA1 interactions	C15orf39 WNK1 MEOX2 WNK2	2.84e-04	31	209	4	int:SPATA1
Interaction	GSC interactions	C15orf39 BCL9 KMT2C BAHCC1 FOXP4 KMT2D	2.91e-04	87	209	6	int:GSC
Interaction	ZNF629 interactions	WDR46 HNF4A HNF4G CIC MEN1 RGS3 YBX2	3.00e-04	123	209	7	int:ZNF629
Interaction	EFEMP1 interactions	MEOX2 ZNF358 RIC8A BAG6 SHANK3 POLR3C KHDRBS1	3.00e-04	123	209	7	int:EFEMP1
Interaction	PAX7 interactions	BCL7C BCL9 CIC KMT2C FOXP4 KMT2D MYH14	3.15e-04	124	209	7	int:PAX7
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	KMT2B LILRB2 PMIS2 LRFN3 EPS8L1 CIC DNAAF3 SSC5D ALDH16A1 MAP3K10 ZNF541 APLP1 PLEKHG2 FAM90A27P LIPE MYH14 DMRTC2 SIX5 SIGLEC11	3.06e-06	1192	211	19	chr19q13
Cytoband	7q35	CLCN1 CTAGE6 CTAGE8 CTAGE15	1.23e-04	55	211	4	7q35
Cytoband	11p15.5	CDHR5 TRPM5 RIC8A CHRNA10 DUSP8	2.25e-04	118	211	5	11p15.5
Cytoband	22q13.3	TCF20 SHANK3	3.12e-04	6	211	2	22q13.3
Cytoband	16p11	ATXN2L BCL7C	4.35e-04	7	211	2	16p11
Cytoband	Ensembl 112 genes in cytogenetic band chr6p21	WDR46 PHF1 TTBK1 PSORS1C2 BAG6 DXO C6orf132 FOXP4 TNXB	5.80e-04	503	211	9	chr6p21
Cytoband	19q13.2	CIC MAP3K10 PLEKHG2 LIPE DMRTC2	1.01e-03	164	211	5	19q13.2
Cytoband	6p21.3	WDR46 PHF1 PSORS1C2 BAG6 DXO TNXB	1.11e-03	250	211	6	6p21.3
Cytoband	3p21.31	FYCO1 USP19 NBEAL2 PLXNB1	1.20e-03	100	211	4	3p21.31
Cytoband	9q32	FKBP15 RGS3 TMEM268	1.34e-03	47	211	3	9q32
Cytoband	19q13.33	ALDH16A1 ZNF541 MYH14 SIGLEC11	1.49e-03	106	211	4	19q13.33
Cytoband	Ensembl 112 genes in cytogenetic band chr9q32	FKBP15 RGS3 TMEM268	1.60e-03	50	211	3	chr9q32
Cytoband	17p13.1	VAMP2 CTC1 ZBTB4 YBX2	2.21e-03	118	211	4	17p13.1
Cytoband	Ensembl 112 genes in cytogenetic band chr12q24	SETD1B UNG GOLGA3 TBX5 CUX2 DHX37 BICDL1	3.25e-03	415	211	7	chr12q24
Cytoband	Ensembl 112 genes in cytogenetic band chr7q35	CTAGE6 CTAGE8 CTAGE15	3.54e-03	66	211	3	chr7q35
Cytoband	Ensembl 112 genes in cytogenetic band chr9q34	ABCA2 SETX CEL ARRDC1 TSC1 NPDC1	4.09e-03	325	211	6	chr9q34
Cytoband	Ensembl 112 genes in cytogenetic band chr22q13	CACNA1I RANGAP1 RTL6 TCF20 SHANK3 MAPK8IP2	4.40e-03	330	211	6	chr22q13
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETD1B KMT2B KMT2C KMT2D	1.23e-04	34	137	4	487
GeneFamily	CTAGE family	CTAGE6 CTAGE8 CTAGE15	1.81e-04	15	137	3	907
GeneFamily	Wiskott-Aldrich Syndrome protein family	WASHC1 WASF2 WASH2P	2.22e-04	16	137	3	14
GeneFamily	PHD finger proteins	KMT2B TRIM24 PHF1 KMT2C KMT2D	6.09e-04	90	137	5	88
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	SCRT1 SALL3 ZNF395 CASZ1 ZNF469 WIZ GLI1 KLF5 ZNF358 ZNF541 ZBTB4 SALL4 HIVEP3 ZFHX2	1.11e-03	718	137	14	28
GeneFamily	CUT class homeoboxes and pseudogenes	CUX2 CUX1	1.98e-03	9	137	2	527
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL	TRNP1 IL16 ARRDC1 TBC1D2B EMILIN2 EPS8L1 CIC VSIR KLF5 MN1 PLXNB1 COL4A6 HSPG2 APLP1 NPDC1 RAB11FIP1 SEZ6L2 EML3 BICDL1 PRKCZ TNXB	2.47e-07	704	209	21	M45672
Coexpression	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP	IL16 ABCA2 MAPK8IP3 PHF1 BMP6 AP1B1 DIAPH1 FRAT1 RGS3 ELF4 CUX1	6.31e-07	199	209	11	M3599
Coexpression	GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN	SETD1B BCL9 KMT2C EHBP1L1 AMBRA1 SLC4A3 RGS3 POLR3C HIVEP3 KMT2D SLC16A10	6.64e-07	200	209	11	M3510
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	SF3B4 NOL6 RUSC1 C15orf39 DENND1C GMIP CASZ1 VSIR MAPK8IP3 EHBP1L1 TMEM259 CACNA1I FKBP15 CTC1 WASHC1 RAB11FIP1 EML3 FAM156A PIGQ HGS ELF4 CUX1	3.75e-06	905	209	22	M40865
Coexpression	GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP	WDR46 BCL9 TTC3 ZBP1 TET3 GOLGA3 SMC4 NCKAP5L KMT2D SLC16A10	4.83e-06	199	209	10	M9269
Coexpression	GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN	RIN3 ZNF395 DENND1C GMIP CARMIL2 PLEKHG2 RGS3 PIANP WASF2 HGS	5.05e-06	200	209	10	M9735
Coexpression	GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP	ARRDC1 TBC1D2B C15orf39 ZNF395 GMIP PTPRJ FRAT1 PIANP WASF2 ELF4	5.05e-06	200	209	10	M9739
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING	VWA5B2 GINM1 ADGRB1 TSC1 NRXN2 TMEM259 MAP3K10 HS3ST4 BAHCC1 DXO HDAC5 CTC1 DHX37 MINK1 ARHGAP17 UBXN1 SEZ6L2 SLC4A3 SHANK3 ARHGEF40 PIANP ZFHX2	8.62e-06	954	209	22	MM3689
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL	TRNP1 ARRDC1 TSC1 EPS8L1 VSIR TMUB1 POM121 NRXN2 KLF5 MN1 PLXNB1 COL4A6 HSPG2 APLP1 NPDC1 RAB11FIP1 SEZ6L2 EML3 BICDL1 FOXP4 PRKCZ TNXB	8.76e-06	955	209	22	M45680
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_OLIGODENDROCYTE_PRECURSOR_CELL_AGEING	WBP2 SF3B4 KMT2B BCL7C ADGRB1 RUSC1 TMUB1 PHLDB1 NRXN2 FRAT1 AMBRA1 UBXN1 PIANP ZFHX2	1.53e-05	446	209	14	MM3691
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	ATXN2L CIC MAPK8IP3 CACTIN TMEM259 ZNF358 DXO RANGAP1 MINK1 ARHGAP17 NCKAP5L KMT2D	1.90e-05	338	209	12	M17094
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL	TRNP1 ARRDC1 C15orf39 EPS8L1 TMUB1 KLF5 MN1 PLXNB1 COL4A6 APLP1 NPDC1 RAB11FIP1 SEZ6L2 BICDL1 FOXP4 PRKCZ	2.02e-05	584	209	16	M45668
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	TBC1D2B ADGRB1 RUSC1 TTC3 SSPOP CASZ1 NRXN2 CACNA1I GOLGA3 FKBP15 APLP1 NPDC1 SALL4 SEZ6L2 SLC4A3 SHANK3 HIVEP3 PIANP OTUD4 ZFHX2 PRKCZ PRRT4 MAPK8IP2	2.76e-05	1106	209	23	M39071
Coexpression	GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN	HNF4A CIC EHBP1L1 PTPRJ NRXN2 TET3 HIVEP3 BICDL1 LIPE	2.85e-05	195	209	9	M7263
Coexpression	VEGF_A_UP.V1_UP	CIC PTPRJ GLI1 MN1 HDAC5 DUSP8 TNS2 RGS3 KMT2D	2.85e-05	195	209	9	M2676
Coexpression	GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN	SETD1B RUSC1 CIC PHF1 PLXNB1 NIBAN1 CTC1 DUSP8 SLC16A2	2.96e-05	196	209	9	M8034
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	RUSC1 BCL9 MEN1 EHBP1L1 HSPG2 TCF20 MINK1 AMBRA1 LIPE	3.34e-05	199	209	9	M7254
Coexpression	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	TSPYL1 ZNF831 TTC3 VSIR PHF1 TMEM259 CTC1 ZBTB4 RGS14	3.34e-05	199	209	9	M8606
Coexpression	GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	IL16 SETX C15orf39 EHBP1L1 NBEAL2 TET3 FRAT1 CD93 RGS14	3.34e-05	199	209	9	M4460
Coexpression	GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	RIN3 GINM1 C15orf39 PTPRJ VAMP2 RGS3 CD93 PRKCZ CUX1	3.47e-05	200	209	9	M9449
Coexpression	GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP	SETD1B TSC1 BCL9 TRIM24 AP1B1 HDAC5 PLEKHG2 AKAP12 RGS14	3.47e-05	200	209	9	M5069
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL	VWA5B2 TRNP1 CASZ1 APLP1 NPDC1 SEZ6L2 HIVEP3 MAPK8IP2	3.61e-05	155	209	8	M45695
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL	VWA5B2 TRNP1 ABCA2 NACAD CASZ1 WNK2 APLP1 NPDC1 SEZ6L2 SLC4A3 STON2 ZFHX2 MAPKBP1	4.44e-05	429	209	13	M45694
Coexpression	RODRIGUES_NTN1_TARGETS_DN	WNK1 VSIR CACNA1I HSPG2 OGFR MINK1 SEZ6L2 MYH14	4.73e-05	161	209	8	M11857
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL	VWA5B2 TRNP1 NACAD CASZ1 APLP1 NPDC1 SEZ6L2 HIVEP3 BICDL1 MAPK8IP2	6.26e-05	268	209	10	M45696
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	ARRDC1 RUSC1 EPS8L1 CASZ1 PLXNB1 NPDC1 ZNF385A C6orf132 BICDL1 PWWP2B MYH14 TMEM268 TNKS1BP1	8.05e-05	455	209	13	M17299
Coexpression	WNT_UP.V1_UP	BCL7C ADGRB1 MFAP2 AP1B1 KCND3 GLI1 ZNF358 MAPKBP1	8.84e-05	176	209	8	M2690
Coexpression	HUTTMANN_B_CLL_POOR_SURVIVAL_UP	RIN3 IL16 LILRB2 EHBP1L1 TMEM259 VAMP2 DIAPH1 OGFR AKAP12 HGS	1.01e-04	284	209	10	M19993
Coexpression	IL21_UP.V1_DN	CEL USP9Y NACAD MEOX2 ZNF358 CUX2 BICDL1 SLC16A2	1.30e-04	186	209	8	M2824
Coexpression	GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP	RIN3 EMILIN2 NBEAL2 TET3 FMNL1 PWWP2B ELF4 CUX1	1.67e-04	193	209	8	M3303
Coexpression	PRC2_EED_DN.V1_DN	WIZ CASKIN2 GLI1 PLXNB1 RANGAP1 APLP1 HIVEP3 LIPE	1.67e-04	193	209	8	M2734
Coexpression	GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN	NOL6 BCL9 TMUB1 URB1 WIZ CHRNA10 DHX37 HIVEP3	1.67e-04	193	209	8	M3137
Coexpression	GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP	EHBP1L1 TMEM259 BAG6 FMNL1 FRAT1 SEZ6L2 BICDL1 KMT2D	1.79e-04	195	209	8	M3400
Coexpression	DOUGLAS_BMI1_TARGETS_UP	ABCA2 SF3B4 INPPL1 RUSC1 C15orf39 BCL9 UNG TBX5 ARHGAP17 APLP1 RAB11FIP1 EML3 PWWP2B TMEM268	1.84e-04	563	209	14	M15103
Coexpression	GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN	CEL MEN1 PHF1 ZBP1 KLF5 BAG6 UBXN1 ELF4	1.99e-04	198	209	8	M7620
Coexpression	GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	SETX FYCO1 EPS8L1 ZC3H12D GOLGA3 DXO HDAC5 CD93	2.06e-04	199	209	8	M9498
Coexpression	GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP	ABCA2 ZNF395 TTC3 TMUB1 SSC5D BAHCC1 AMH SIX5	2.06e-04	199	209	8	M7520
Coexpression	GSE3982_EOSINOPHIL_VS_MAST_CELL_UP	RIN3 LILRB2 USP19 KLF5 FMNL1 DUSP8 APLP1 ELF4	2.06e-04	199	209	8	M5397
Coexpression	GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN	C15orf39 TSC1 KMT2C BAG6 WASHC1 AMBRA1 KHDRBS1 CUX1	2.13e-04	200	209	8	M8278
Coexpression	GSE360_CTRL_VS_L_MAJOR_MAC_UP	ZSWIM8 ABCA2 TBC1D2B POM121 APLP1 SLC4A3 POLR3C RGS14	2.13e-04	200	209	8	M5160
Coexpression	GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN	ZNF395 AP1B1 VAMP2 CACNA1I HDAC5 RGS14 WASF2 ELF4	2.13e-04	200	209	8	M9002
Coexpression	PEREZ_TP53_AND_TP63_TARGETS	GABRE CASZ1 VSIR PTPRJ ZNF385A RAB11FIP1 SHANK3 FOXP4	2.69e-04	207	209	8	M14566
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HSERT	ADGRB1 CASZ1 NRXN2 HS3ST4 APLP1 SEZ6L2 SLC4A3 SHANK3 ZFHX2 PRKCZ PRRT4 MAPK8IP2	2.85e-04	450	209	12	M39072
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2	RIN3 ANKS6 KMT2B FYCO1 EPS8L1 ZNF395 TSC22D2 BCL9 MFAP2 TRPM5 GLI1 MN1 NIBAN1 RTL6 HDAC5 ARHGAP17 APLP1 NCKAP5L SLC4A3 YBX2 BICDL1 ARHGEF40 PIANP ADAMTS7 SLC16A2 MYH14 SIX5 ELF4	1.69e-05	1208	206	28	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2
ToppCell	PND01-03-samps-Epithelial-Alveolar_epithelial-AT1\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	TRNP1 NACAD KLF5 PLXNB1 COL4A6 RAB11FIP1 C6orf132 BICDL1 MYH14 CUX1	6.90e-09	165	211	10	b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	RIN3 NACAD VSIR ZNF469 EHBP1L1 NHS COL4A6 NCKAP5L LIPE ELF4	3.39e-08	195	211	10	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GABRE EPS8L1 CASZ1 URB1 WNK2 DUSP8 SALL4 RAB11FIP1 MYH14	1.97e-07	179	211	9	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	PRAG1 CIC SSC5D NRXN2 GLI1 SHANK3 ARHGEF40 SOWAHA SIX5	2.98e-07	188	211	9	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	(2)_Fibroblasts-(21)_Fibro-2\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	TRNP1 EMILIN2 CDHR5 SSC5D NIBAN1 ZFHX2 TNXB CUX1 SLC16A10	3.41e-07	191	211	9	5ee353c79055c08e8a3e2b43a0345bceb09f3890
ToppCell	Thalamus-Neuronal\|Thalamus / BrainAtlas - Mouse McCarroll V32	RUSC1 TTC3 MAPK8IP3 VAMP2 RANGAP1 CARMIL2 DUSP8 PIANP MAPK8IP2	3.72e-07	193	211	9	712a4acd1167e43543950bc819ff11984e6f718d
ToppCell	Healthy/Control-Classical_Monocyte\|World / Disease group and Cell class	LILRB2 EMILIN2 C15orf39 VSIR TET3 ZNF385A RAB11FIP1 CD93 ARHGEF40	4.81e-07	199	211	9	527c767a09f911e319f7ad230b6518cebc0f367d
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	RUSC1 TTC3 CRACD NRXN2 MN1 CUX2 APLP1 SEZ6L2 SLC4A3	5.02e-07	200	211	9	5b3df61ff421846ef4cabf1bd5355534c8b95509
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRNP1 HNF4G KLF5 NHS WNK2 COL4A6 SLC4A3 SOWAHA	1.50e-06	169	211	8	30141f76e9bfc2b4586429857c72dbc85ba65cc9
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	VWA5B2 TRNP1 HNF4A HNF4G HS3ST4 APLP1 SEZ6L2 CDRT15P3	2.71e-06	183	211	8	8820cfed27b292bc0bc9cde4005219ed41900552
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RIN3 VSIR EHBP1L1 AP1B1 FMNL1 DUSP8 CD93 SLC16A10	2.94e-06	185	211	8	76fc5bbb71e42c0eb70474efcd3a71a7b2633f24
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CASZ1 CRACD BMP6 PTPRJ NHS CACNA1I HS3ST4 TCF20	3.18e-06	187	211	8	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LILRB2 EMILIN2 C15orf39 VSIR MN1 TET3 ZNF385A CD93	3.87e-06	192	211	8	0219093e7921a0db78053aee13ec480b520f5662
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LILRB2 EMILIN2 C15orf39 VSIR MN1 TET3 ZNF385A CD93	3.87e-06	192	211	8	f14ee74ac3275601749a23c5efe39c2413a62e1a
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEL CDHR5 HNF4A KLF5 RAB11FIP1 C6orf132 MYH14 SNORC	4.18e-06	194	211	8	07d8e38cbc2c7f0564c14f7c365f345f901b73b2
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NRXN2 CUX2 CARMIL2 APLP1 NPDC1 SEZ6L2 TMEM132E MAPK8IP2	4.34e-06	195	211	8	5a6a5048af638872700b76b7c71a8fa3fb8d3772
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LILRB2 EMILIN2 KMT2C NIBAN1 PLEKHG2 RAB11FIP1 CD93 ARHGEF40	4.85e-06	198	211	8	d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LILRB2 EMILIN2 C15orf39 VSIR ZNF385A RAB11FIP1 CD93 ARHGEF40	4.85e-06	198	211	8	06201b34d3e38f22c93b759511f7b376504bac06
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LILRB2 EMILIN2 C15orf39 VSIR ZNF385A RAB11FIP1 CD93 ARHGEF40	4.85e-06	198	211	8	1ca91559fef231896e16180f5e050155c38f7cfa
ToppCell	Healthy_donor-Classical_Monocyte\|World / disease group, cell group and cell class (v2)	LILRB2 EMILIN2 C15orf39 VSIR ZNF385A RAB11FIP1 CD93 ARHGEF40	5.04e-06	199	211	8	45e9099a13becb1e235435ceaaffb92b82ce34ee
ToppCell	(02)_MMP9/10+\|World / shred by cell type by condition	CEL MFAP2 PHLDB1 AFAP1L2 MN1 CUX2 ARHGEF40 ADAMTS7	5.04e-06	199	211	8	3f78eddeaa67d3b767aa38de765632166b09a4f0
ToppCell	mild_COVID-19_(asymptomatic)-Classical_Monocyte\|World / disease group, cell group and cell class (v2)	LILRB2 EMILIN2 C15orf39 EHBP1L1 TET3 ZNF385A HIVEP3 CD93	5.04e-06	199	211	8	727122b6f4ca265d2826c9271b10a4215a9d45a3
ToppCell	Children_(3_yrs)-Immune-monocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RIN3 LILRB2 EMILIN2 VSIR EHBP1L1 PTPRJ TET3 CD93	5.23e-06	200	211	8	881ab995c90d75fd987d6e8f1f926a4bfcc4235f
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	RUSC1 NACAD CRACD NRXN2 SEZ6L2 SLC4A3 HIVEP3 CUX1	5.23e-06	200	211	8	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	Monocytes-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	LILRB2 EMILIN2 VSIR FMNL1 FAM156A CD93 RGS14	7.53e-06	150	211	7	b580b06795973fec16ea6f7f5b6b9d580bf7fcf5
ToppCell	facs-Lung-Endomucin-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF831 MEN1 TCF20 SMC4 AMBRA1 RGS14 BICDL1	1.15e-05	160	211	7	0fee84844733d36805e1df90ca09478169746708
ToppCell	facs-Lung-Endomucin-3m-Lymphocytic-CD4+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF831 MEN1 TCF20 SMC4 AMBRA1 RGS14 BICDL1	1.15e-05	160	211	7	5c68d6a76c59e3a7e668ae5471396478a55756ac
ToppCell	droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EMILIN2 ZBP1 DNAAF3 FMNL1 NIBAN1 ELF4 SLC16A10	1.35e-05	164	211	7	cd0794f84dfd346807e2d803723718b7f22e9232
ToppCell	droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EMILIN2 ZBP1 DNAAF3 FMNL1 NIBAN1 ELF4 SLC16A10	1.35e-05	164	211	7	12251a49fd4af32d4edb58046245548c260cf04b
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ANKS6 EPS8L1 CASKIN2 NHS RTL6 TNKS1BP1 SIGLEC11	1.35e-05	164	211	7	d6806deabf5f5c355934387be2baae125ac33fb8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SALL3 WDR46 CIC UBXN1 YBX2 SOWAHA RGL4	1.40e-05	165	211	7	50f1fa7434ebb777e15d5273d1ff41070cff6db3
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRNP1 HNF4G KLF5 NHS COL4A6 SLC4A3 SOWAHA	1.52e-05	167	211	7	cf6206c506715cd846799c62cf7c06e3fa99f7af
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D2B ADGRB1 WNK2 COL4A6 SOWAHA STON2 FCRLB	1.70e-05	170	211	7	a121e10099faaeb60251eec162f38caf7c4238c2
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	INPPL1 NOL6 TSC1 PHLDB1 PTPRJ TNXB	1.91e-05	116	211	6	f2bf9599040f43b5ea8724841d7b71c0a859c016
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RIN3 EMILIN2 EHBP1L1 FMNL1 DUSP8 PLEKHG2 SLC16A10	1.98e-05	174	211	7	062e7bd9072ca7ee68e09b1da28af13f1bc60b44
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D2B ADGRB1 WNK2 COL4A6 SOWAHA STON2 FCRLB	2.05e-05	175	211	7	f7cd2ef79d91d64976fcdb5f1e7343b24ba27456
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 LILRB2 EMILIN2 GMIP VSIR EHBP1L1 FMNL1	2.05e-05	175	211	7	e991ffa4d1d278a011592b9915cd35fe76db20cc
ToppCell	droplet-Fat-Mat-18m-Hematologic-monocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIN3 C15orf39 GMIP KLF5 NIBAN1 FRAT1 STON2	2.13e-05	176	211	7	867936a20f73f638055c19c8d88834aa2cc657cf
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA2 SALL3 CEL USP9Y WNK1 PLXNB1 SLC52A1	2.21e-05	177	211	7	c9e8149639551a4c8daa90fcb2b895fdcff2e2ba
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	VWA5B2 TRNP1 HNF4G APLP1 SEZ6L2 SOWAHA MAPK8IP2	2.37e-05	179	211	7	06f92c884189197c86793191c05f65e34925c097
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL16 TSC1 ZNF831 AFAP1L2 NIBAN1 MAGEE1 MAPKBP1	2.37e-05	179	211	7	6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL16 ZNF831 ZC3H12D FMNL1 CARMIL2 RAB11FIP1 HIVEP3	2.73e-05	183	211	7	450c30d2e389fcb17825394c27f9ccc4f33022e3
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNF4A HNF4G KLF5 YBX2 MALRD1 MYH14 SNORC	2.73e-05	183	211	7	0d21befacefc6c597e7b501ed41b7fe9385a78df
ToppCell	18-Distal-Epithelial-Neuroendocrine\|Distal / Age, Tissue, Lineage and Cell class	VWA5B2 BEST3 KCND3 APLP1 NPDC1 BICDL1 MAPK8IP2	2.93e-05	185	211	7	f8fc7b12b4e18d23d84e95488be93c4352d325f3
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	IL16 MEOX2 CRACD SSC5D PHLDB1 TBX5 TNXB	3.13e-05	187	211	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	Endothelial-A-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	BMP6 CASKIN2 HSPG2 NPDC1 AKAP12 CD93 TNXB	3.13e-05	187	211	7	febe0b99a6a815ce687160a0e7af55228b1d5beb
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	CASZ1 KCND3 WNK2 TBX5 NIBAN1 SLC4A3 RGS3	3.24e-05	188	211	7	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRAG1 KLF5 NBEAL2 HSPG2 RAB11FIP1 MYH14 PRKCZ	3.24e-05	188	211	7	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CASKIN2 HSPG2 TNS2 NPDC1 SHANK3 CD93 TNXB	3.24e-05	188	211	7	a37edd8f9e4a4e336b5acbb0407d3d275975cee8
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIR CASKIN2 HSPG2 NPDC1 RGS3 SHANK3 CD93	3.35e-05	189	211	7	db09d591b885ce2bc9e353f08b6694e2192582e1
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL16 DENND1C ZNF831 CACNA1I FMNL1 BICDL1 RGL4	3.35e-05	189	211	7	5c92516c3745ccbd480b15bb2b9077ab1d9ee5a0
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LILRB2 EMILIN2 VSIR EHBP1L1 PLEKHG2 ZNF385A CD93	3.47e-05	190	211	7	00ef6ec71353e42260c0d807d7da65b63154c288
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MFAP2 GLI1 MN1 NIBAN1 AKAP12 ARHGEF40 TNXB	3.47e-05	190	211	7	947807863a9b247c301c6cf63d6fd5a2c8018e66
ToppCell	PCW_10-12-Epithelial-Epithelial_neuroendo\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	VWA5B2 TRNP1 BEST3 HNF4G KCND3 BICDL1 MAPK8IP2	3.47e-05	190	211	7	2375e604eacd38f61f3e661ba2f76d286fcceca7
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RIN3 LILRB2 EMILIN2 VSIR EHBP1L1 DIAPH1 FMNL1	3.47e-05	190	211	7	ad297172a74a80ed5c10f921e15efd1da0fd2d6b
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LILRB2 EMILIN2 VSIR EHBP1L1 PLEKHG2 ZNF385A CD93	3.47e-05	190	211	7	18c020ca9a23399214133ec255ab870e0060f2e1
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	CASZ1 KCND3 WNK2 TBX5 NIBAN1 SLC4A3 RGS3	3.59e-05	191	211	7	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LRFN3 MEOX2 BMP6 HSPG2 NPDC1 SHANK3 TNKS1BP1	3.59e-05	191	211	7	dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIR HSPG2 NIBAN1 NPDC1 RGS3 SHANK3 CD93	3.71e-05	192	211	7	1f35efb0765e05f7f9c881849953bef3965be25a
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEL CDHR5 HNF4A KLF5 RAB11FIP1 C6orf132 MYH14	3.83e-05	193	211	7	32eb026d4317c1499d51294d396dfd5f293f9deb
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEL CDHR5 HNF4A KLF5 RAB11FIP1 C6orf132 MYH14	3.83e-05	193	211	7	930df79b0600f43617052313294be33bcf5631f0
ToppCell	nucseq-Immune-Immune_Myeloid-pMON-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RIN3 LILRB2 EMILIN2 VSIR EHBP1L1 PTPRJ FMNL1	3.96e-05	194	211	7	e237384b02be460d44eeada3026a5691c66f6fc1
ToppCell	nucseq-Immune-Immune_Myeloid-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RIN3 LILRB2 EMILIN2 VSIR EHBP1L1 PTPRJ FMNL1	3.96e-05	194	211	7	0bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell	Mesenchymal_cells-Arteriolar_fibro.\|World / Lineage and Cell class	MEOX2 SSC5D MFAP2 MN1 HSPG2 NPDC1 TNXB	3.96e-05	194	211	7	c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LILRB2 EMILIN2 VSIR AP1B1 PTPRJ TET3 CD93	3.96e-05	194	211	7	663e7e7fe48157e808b4f1a0ea6ad41944e857a2
ToppCell	PND01-03-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	EMILIN2 CACNA1I FMNL1 TMEM268 FCRLB TNXB	3.97e-05	132	211	6	617644597726e881cd343e57f6edb5a98473b421
ToppCell	ASK440-Endothelial-Endothelium\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	SSC5D BMP6 CASKIN2 HSPG2 TNS2 NPDC1 CD93	4.09e-05	195	211	7	304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LILRB2 EMILIN2 VSIR ZNF385A RAB11FIP1 CD93 ARHGEF40	4.09e-05	195	211	7	0110b976f98561ecd2e20ff6e7e3960a401bb7c2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RIN3 LILRB2 EMILIN2 DUSP8 PLEKHG2 CD93 SLC16A10	4.09e-05	195	211	7	0ec1b572bbb92b6da3440139366a4c1743b1ad92
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GMIP VSIR NBEAL2 DIAPH1 NIBAN1 ZNF385A ARHGEF40	4.09e-05	195	211	7	ae98215b7b7f22f1aca690920ce6092dc4a3c7db
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GMIP VSIR NBEAL2 DIAPH1 NIBAN1 ZNF385A ARHGEF40	4.09e-05	195	211	7	6fcab7aa4db958ccad0300adea9aaae52ace5bff
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LILRB2 EMILIN2 VSIR ZNF385A RAB11FIP1 CD93 ARHGEF40	4.09e-05	195	211	7	050fc59b328391d6e3ce23051764a842dcbb3144
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIR CASKIN2 HSPG2 NPDC1 RGS3 SHANK3 CD93	4.23e-05	196	211	7	ae46d4b00be92e64e46252dcc156161b171eded4
ToppCell	COVID-19-Myeloid-Monocytes\|COVID-19 / group, cell type (main and fine annotations)	RIN3 LILRB2 EMILIN2 VSIR PTPRJ TET3 FMNL1	4.23e-05	196	211	7	04d710267658ea5601ae2cfb4ed5acb8a29bd8a1
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	ATXN2L BCL7C TTC3 WNK1 KMT2C VAMP2 FMNL1	4.23e-05	196	211	7	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNF4A HNF4G KLF5 MALRD1 MYH14 SNORC LBX2	4.23e-05	196	211	7	4deaadb9796b907b7480fb7af5ed76ebad240850
ToppCell	Children_(3_yrs)-Immune-monocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RIN3 LILRB2 EMILIN2 VSIR PTPRJ TET3 CD93	4.23e-05	196	211	7	cacd69be72e6167814f7adea7c5fa114f3103bbb
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VSIR HSPG2 NIBAN1 NPDC1 RGS3 SHANK3 CD93	4.37e-05	197	211	7	98e34e8612f111bb667a574de1faaa785d318ca4
ToppCell	Fetal_29-31_weeks-Immune-monocyte\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RIN3 LILRB2 EMILIN2 VSIR EHBP1L1 PTPRJ FMNL1	4.37e-05	197	211	7	48a8169a4d33c6a68d66bcd936861c75cb4b60ef
ToppCell	390C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BCL7C MFAP2 RAB11FIP1 AKAP12 STON2 PRKCZ TNXB	4.37e-05	197	211	7	c84e988c2ad06087aafda9e3b68e9e72fd0e75f1
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNF4A HNF4G KLF5 MALRD1 MYH14 SNORC LBX2	4.37e-05	197	211	7	f097e729f515e7945b9482e9f9dbc9536b90f0bb
ToppCell	control-Myeloid-Non-resident_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LILRB2 EMILIN2 RAB11FIP1 CD93 WASF2 HGS SLC16A10	4.37e-05	197	211	7	df2fe36cb96e2565a9d21c24cb4e451e8befd4be
ToppCell	Mesenchymal_cells-Arteriolar_fibro.\|Mesenchymal_cells / Lineage and Cell class	VSIR MEOX2 SSC5D MFAP2 MN1 HSPG2 TNXB	4.37e-05	197	211	7	cb321836980e7b4efbb9284c6af7ccd34079d2be
ToppCell	390C-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BCL7C MFAP2 RAB11FIP1 AKAP12 STON2 PRKCZ TNXB	4.37e-05	197	211	7	6195f945b3fd6da07907619267d49e96d1044f8f
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RIN3 LILRB2 EMILIN2 VSIR EHBP1L1 PTPRJ FMNL1	4.51e-05	198	211	7	ea34096bee852a7e996f097fa279381afa8f86ff
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LILRB2 EMILIN2 TET3 PLEKHG2 ZNF385A CD93 ARHGEF40	4.51e-05	198	211	7	a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCell	Endothelial_cells\|World / lung cells shred on cell class, cell subclass, sample id	CASKIN2 HSPG2 NPDC1 SHANK3 AKAP12 CD93 TNXB	4.51e-05	198	211	7	b93effa428ec036542fa21647dfef9589c64640f
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NACAD TTBK1 NHS COL4A6 APLP1 FAM156A ZFHX2	4.51e-05	198	211	7	d6812494874be0c14361ac2ac3e418b335bb8f55
ToppCell	5'-Adult-Distal_Rectal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA2 NBEAL2 WNK2 PLXNB1 NPDC1 SNORC TNXB	4.51e-05	198	211	7	db26c20321f9ab102d6484f22ddb2bde684067b1
ToppCell	Immune-monocyte\|World / Lineage, Cell type, age group and donor	RIN3 LILRB2 EMILIN2 VSIR EHBP1L1 PTPRJ FMNL1	4.51e-05	198	211	7	d3622da252fd580f1dc5c7478a8e23df5ec083cf
ToppCell	5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEL NBEAL2 WNK2 RAB11FIP1 SEZ6L2 MALRD1 SNORC	4.65e-05	199	211	7	f544229f471b4717166dd4b588399afe45cc31b5
ToppCell	Sepsis-Bac-SEP-Lymphocyte-T/NK-dn_T\|Bac-SEP / Disease, condition lineage and cell class	CASZ1 MEN1 AFAP1L2 KLF5 TCF20 MAGEE1 FCRLB	4.65e-05	199	211	7	4150a479b80596accf679b37aa9b0ac15cc132b2
ToppCell	Healthy_donor-Classical_Monocyte\|Healthy_donor / disease group, cell group and cell class (v2)	LILRB2 EMILIN2 C15orf39 VSIR ZNF385A CD93 ARHGEF40	4.65e-05	199	211	7	af3a80dbf5e0306b80f420fd41f1aaed81fe9c46
ToppCell	Healthy/Control-Classical_Monocyte\|Healthy/Control / Disease group and Cell class	LILRB2 EMILIN2 C15orf39 VSIR ZNF385A CD93 ARHGEF40	4.65e-05	199	211	7	4e8c7445d32fd2b7a50524dcd52141e76850c3df
ToppCell	mild_COVID-19_(asymptomatic)-Classical_Monocyte\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	LILRB2 EMILIN2 C15orf39 VSIR EHBP1L1 ZNF385A CD93	4.65e-05	199	211	7	73a98d19871ffbc3c631de330998d42e9afa6da2
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_3\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	VSIR NRXN2 ZC3H12D MN1 MALRD1 PRRT4	4.69e-05	136	211	6	5e209185b5f6e9347829fc9066f0b2c3711df057
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	TTC3 VAMP2 MN1 APLP1 NPDC1 SEZ6L2 HIVEP3	4.80e-05	200	211	7	84e4565d28a02700bf7f6730d1b3a58744ca0aea
ToppCell	Parenchymal-10x5prime-Endothelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CASKIN2 HSPG2 NPDC1 SHANK3 AKAP12 CD93 TNXB	4.80e-05	200	211	7	0e648e9eb96c83a94505d07323785a7a40997eb0
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CASKIN2 HSPG2 TNS2 NPDC1 SHANK3 CD93 TNXB	4.80e-05	200	211	7	2e47888e041ec3d265425d1df97b6665c6da889c
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	TTC3 CRACD MN1 CUX2 APLP1 SEZ6L2 HIVEP3	4.80e-05	200	211	7	306926cb7a847871641f02e03d52dc56fd55711c
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	ATXN2L LILRB2 CIC URB1 PHLDB1 WIZ CASKIN2 BAHCC1 TBX5 OGFR MINK1 SMC4 TNS2 UBXN1 ZFHX2	4.18e-10	198	207	15	5583_DN
Drug	DAPH; Up 200; 10uM; PC3; HG-U133A	ATXN2L IL16 ABCA2 SETX KMT2B NOL6 TSC1 CIC CACTIN WIZ TNS2 NPDC1 MAPKBP1 MAPK8IP2	4.26e-09	199	207	14	578_UP
Drug	Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	ATXN2L LRFN3 TBC1D2B BCL9 CACTIN EHBP1L1 WIZ VAMP2 HSPG2 OGFR RGS3 MAPKBP1	2.70e-07	197	207	12	2814_DN
Drug	Asiaticoside [16830-15-2]; Down 200; 4.2uM; HL60; HT_HG-U133A	EPS8L1 DENND1C GMIP WNK1 CIC CACTIN KLF5 RANGAP1 OGFR DUSP8 EML3 MAPKBP1	2.85e-07	198	207	12	2943_DN
Drug	Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A	KMT2B CASZ1 MAPK8IP3 CASKIN2 HSPG2 HDAC5 OGFR MINK1 UBXN1 RGS14 MAPK8IP2 SLC16A10	3.01e-07	199	207	12	4555_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	IL16 C15orf39 CACNA1I OGFR MINK1 TNS2 SLC4A3 RGS3 HIVEP3 ARHGEF40 SLC16A10	1.73e-06	194	207	11	5914_DN
Drug	Sulfadoxine [2447-57-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A	DENND1C WNK1 BMP6 PHLDB1 WIZ VAMP2 SLC52A1 MINK1 UBXN1 BICDL1 ELF4	1.92e-06	196	207	11	7205_UP
Drug	CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A	PHLDB1 WIZ CASKIN2 ZNF358 VAMP2 HSPG2 MINK1 DUSP8 SLC4A3 PIGQ SLC16A10	1.92e-06	196	207	11	4560_DN
Drug	Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A	ABCA2 PHLDB1 EHBP1L1 WIZ VAMP2 HDAC5 DUSP8 SEZ6L2 EML3 PIGQ HIVEP3	1.92e-06	196	207	11	3324_DN
Drug	Spaglumic acid [4910-46-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A	ABCA2 URB1 PHLDB1 CASKIN2 VAMP2 DIAPH1 PDZD8 CTC1 OGFR SLC16A2 ELF4	2.01e-06	197	207	11	7465_DN
Drug	Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	KMT2B EPS8L1 MAPK8IP3 URB1 PHLDB1 CASKIN2 KLF5 VAMP2 MINK1 SEZ6L2 EML3	2.01e-06	197	207	11	7434_DN
Drug	Droperidol [548-73-2]; Up 200; 10.6uM; PC3; HT_HG-U133A	IL16 LILRB2 TBC1D2B CDHR5 URB1 PHLDB1 NRXN2 CHRNA10 HSPG2 RGS14 ARHGEF40	2.01e-06	197	207	11	4629_UP
Drug	Condelphine [7633-69-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ATXN2L RIN3 ABCA2 LRFN3 MAPK8IP3 PHLDB1 WIZ OGFR RGS3 PIGQ MAPK8IP2	2.01e-06	197	207	11	3538_DN
Drug	Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A	INPPL1 NOL6 URB1 CASKIN2 VAMP2 RANGAP1 OGFR MINK1 HIVEP3 ELF4 SLC16A10	2.12e-06	198	207	11	4498_DN
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; PC3; HT_HG-U133A	RIN3 LRFN3 EPS8L1 GMIP CASZ1 PHLDB1 CASKIN2 TMEM259 NBEAL2 RANGAP1 MINK1	2.12e-06	198	207	11	7310_DN
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A	ABCA2 LRFN3 C15orf39 EPS8L1 CIC PHLDB1 WIZ CASKIN2 TMEM259 EML3 SLC16A10	2.12e-06	198	207	11	6016_DN
Drug	Iobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A	SETX KMT2B LILRB2 EPS8L1 TSC22D2 USP19 FMNL1 RANGAP1 HDAC5 OGFR ELF4	2.22e-06	199	207	11	1729_UP
Drug	Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A	SETD1B BCL7C WNK1 MAPK8IP3 CACTIN DIAPH1 BAHCC1 RANGAP1 SMC4 HIVEP3 ELF4	2.22e-06	199	207	11	1568_DN
Drug	Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A	LRFN3 C15orf39 URB1 NBEAL2 VAMP2 DIAPH1 OGFR MINK1 AMBRA1 RGS3 EML3	2.22e-06	199	207	11	7473_DN
Drug	Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A	TBC1D2B GMIP USP19 EHBP1L1 WIZ CASKIN2 BAHCC1 OGFR TNS2 OTUD4 MAPKBP1	2.33e-06	200	207	11	3442_DN
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A	ATXN2L ABCA2 LRFN3 PHLDB1 EHBP1L1 BAHCC1 HSPG2 MINK1 APLP1 SLC4A3	7.89e-06	185	207	10	4327_DN
Drug	Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A	KMT2B EPS8L1 WNK1 URB1 CASKIN2 MINK1 EML3 POLR3C PIGQ MAPK8IP2	1.09e-05	192	207	10	1829_UP
Drug	Clotrimazole [23593-75-1]; Down 200; 11.6uM; PC3; HT_HG-U133A	ABCA2 TBC1D2B USP19 TMEM259 ZNF358 BAHCC1 OGFR MINK1 RGS14 MYH14	1.14e-05	193	207	10	5726_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	ZSWIM8 C15orf39 EHBP1L1 KLF5 VAMP2 BAHCC1 OGFR DUSP8 ELF4 SLC16A10	1.14e-05	193	207	10	5215_DN
Drug	Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A	ZSWIM8 RIN3 ABCA2 CIC USP19 EHBP1L1 PLXNB1 RANGAP1 OGFR PIGQ	1.20e-05	194	207	10	6769_UP
Drug	Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ATXN2L C15orf39 WNK1 USP19 EHBP1L1 CASKIN2 VAMP2 HDAC5 MINK1 SMC4	1.20e-05	194	207	10	2792_DN
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	ATXN2L RIN3 ABCA2 WNK1 URB1 WIZ TMEM259 VAMP2 OGFR ZFHX2	1.20e-05	194	207	10	3674_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A	ZSWIM8 IL16 HNF4A MAPK8IP3 CACNA1I CHRNA10 MINK1 SLC4A3 RGS14 BICDL1	1.25e-05	195	207	10	6063_UP
Drug	Fillalbin [4540-25-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ATXN2L ABCA2 CIC EHBP1L1 WIZ SLC52A1 MINK1 TNS2 PIGQ KHDRBS1	1.25e-05	195	207	10	2813_DN
Drug	5213008; Down 200; 18uM; MCF7; HT_HG-U133A_EA	WBP2 EPS8L1 PHF1 CACTIN EHBP1L1 KLF5 OGFR TNS2 APLP1 SEZ6L2	1.25e-05	195	207	10	898_DN
Drug	Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A	RIN3 KMT2B C15orf39 CASKIN2 ZNF358 COL4A6 CTC1 MINK1 SLC4A3 EML3	1.25e-05	195	207	10	7372_UP
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ABCA2 C15orf39 CASZ1 CACTIN WIZ CASKIN2 GOLGA3 AMBRA1 TNS2 SEZ6L2	1.31e-05	196	207	10	7181_DN
Drug	Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	EPS8L1 CIC USP19 WIZ ZNF358 BAHCC1 HDAC5 MINK1 ZFHX2 ELF4	1.31e-05	196	207	10	3327_DN
Drug	Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A	ZSWIM8 BCL9 CIC CACTIN WIZ DIAPH1 PLXNB1 MINK1 EML3 ELF4	1.31e-05	196	207	10	1679_DN
Drug	Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A	ABCA2 CEL C15orf39 HNF4A PHF1 PHLDB1 ZNF358 CACNA1I RANGAP1 UBXN1	1.31e-05	196	207	10	3315_UP
Drug	Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A	ZSWIM8 EPS8L1 MAPK8IP3 URB1 EHBP1L1 NBEAL2 VAMP2 HDAC5 EML3 ELF4	1.31e-05	196	207	10	2406_DN
Drug	Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; PC3; HT_HG-U133A	TBC1D2B WNK1 PHF1 PHLDB1 VAMP2 BAHCC1 MINK1 AMBRA1 EML3 ZFHX2	1.31e-05	196	207	10	5734_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	EPS8L1 WNK1 CIC CACTIN PHLDB1 WIZ OGFR MINK1 RGS3 EML3	1.31e-05	196	207	10	4826_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	EPS8L1 PHLDB1 EHBP1L1 KCND3 ZNF358 CACNA1I AMH SLC52A1 UBXN1 SLC16A10	1.37e-05	197	207	10	5953_DN
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	USP19 WIZ NBEAL2 HSPG2 FKBP15 HDAC5 RGS14 MYH14 ELF4 SLC16A10	1.37e-05	197	207	10	4532_DN
Drug	Dydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A	RIN3 ABCA2 KMT2B PHLDB1 TMEM259 VAMP2 SMC4 TNS2 AKAP12 ELF4	1.37e-05	197	207	10	4836_DN
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	KMT2B EPS8L1 PHLDB1 EHBP1L1 BAHCC1 HDAC5 MINK1 AMBRA1 PIGQ ZFHX2	1.37e-05	197	207	10	3343_DN
Drug	Ginkgolide A [15291-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A	ATXN2L ABCA2 LILRB2 PHF1 URB1 HSPG2 HDAC5 MINK1 UBXN1 MYH14	1.37e-05	197	207	10	4121_UP
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	WBP2 EPS8L1 MAPK8IP3 PHLDB1 CASKIN2 NBEAL2 OGFR MINK1 DUSP8 TNS2	1.37e-05	197	207	10	5211_DN
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; PC3; HT_HG-U133A	SETX MAPK8IP3 EHBP1L1 TMEM259 MN1 FKBP15 OGFR MINK1 MYH14 ELF4	1.37e-05	197	207	10	6620_DN
Drug	Acyclovir [59277-89-3]; Up 200; 17.8uM; MCF7; HT_HG-U133A	ABCA2 EPS8L1 ZNF358 CACNA1I BAHCC1 TBX5 FKBP15 FRAT1 OGFR MYH14	1.37e-05	197	207	10	1543_UP
Drug	sulindac; Down 200; 100uM; MCF7; HG-U133A	ATXN2L FYCO1 MAPK8IP3 PTPRJ BAHCC1 HDAC5 POLR3C HIVEP3 ADAMTS7 ZFHX2	1.37e-05	197	207	10	168_DN
Drug	Nadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A	ATXN2L IL16 LILRB2 HNF4A MN1 PLXNB1 TNS2 RGS14 ARHGEF40 KMT2D	1.37e-05	197	207	10	6091_UP
Drug	LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A	WBP2 KMT2B INPPL1 NOL6 DENND1C EHBP1L1 DIAPH1 HDAC5 RGS14 PRKCZ	1.37e-05	197	207	10	1157_DN
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A	ZSWIM8 SETD1B USP9Y URB1 EHBP1L1 WIZ CACNA1I BAHCC1 PIGQ HIVEP3	1.37e-05	197	207	10	6801_UP
Drug	Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; PC3; HT_HG-U133A	PHF1 AP1B1 CASKIN2 MN1 CTC1 MINK1 HIVEP3 RGS14 OTUD4 ELF4	1.37e-05	197	207	10	4658_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	C15orf39 PHLDB1 PLXNB1 OGFR MINK1 SMC4 UBXN1 EML3 RGS14 BICDL1	1.37e-05	197	207	10	7440_DN
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; PC3; HT_HG-U133A	ABCA2 KMT2B CEL URB1 VAMP2 CHRNA10 PLXNB1 FKBP15 MYH14 OTUD4	1.37e-05	197	207	10	4684_DN
Drug	Demecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A	EPS8L1 WNK1 CIC CACTIN EHBP1L1 CASKIN2 TMEM259 DIAPH1 MINK1 EML3	1.37e-05	197	207	10	2773_DN
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	CIC CACTIN EHBP1L1 WIZ PLXNB1 BAHCC1 TNS2 APLP1 BICDL1 ELF4	1.37e-05	197	207	10	3877_DN
Drug	Bethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A	RIN3 ABCA2 EPS8L1 CIC PHLDB1 EHBP1L1 VAMP2 PLXNB1 OGFR EML3	1.43e-05	198	207	10	3537_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ATXN2L RIN3 TBC1D2B CASKIN2 BAHCC1 OGFR TNS2 SLC16A2 OTUD4 ELF4	1.43e-05	198	207	10	2320_DN
Drug	Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	ABCA2 C15orf39 BCL9 PHF1 CACTIN OGFR MINK1 SMC4 AMBRA1 MAPKBP1	1.43e-05	198	207	10	7200_DN
Drug	Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; MCF7; HT_HG-U133A	KMT2B LILRB2 BCL9 WIZ TMEM259 HSPG2 FKBP15 MINK1 ELF4 SLC16A10	1.43e-05	198	207	10	3581_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ZSWIM8 NOL6 C15orf39 EPS8L1 ZNF395 CACTIN TMEM259 TNS2 EML3 ELF4	1.43e-05	198	207	10	7177_DN
Drug	arachidonic acid sodium salt; Up 200; 10uM; MCF7; HG-U133A	TBC1D2B EPS8L1 TSC22D2 EHBP1L1 WIZ CACNA1I PLXNB1 BAHCC1 EML3 SLC16A2	1.43e-05	198	207	10	441_UP
Drug	Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A	RIN3 MAPK8IP3 KCND3 KLF5 CHRNA10 OGFR APLP1 EML3 HIVEP3 ZFHX2	1.49e-05	199	207	10	6240_UP
Drug	Ethosuximide [77-67-8]; Up 200; 28.4uM; HL60; HG-U133A	ZSWIM8 SETX LILRB2 EHBP1L1 KLF5 NBEAL2 FMNL1 EML3 PIGQ MYH14	1.49e-05	199	207	10	1433_UP
Drug	Azathymine, 6 [932-53-6]; Up 200; 31.4uM; PC3; HT_HG-U133A	ATXN2L EPS8L1 TSC22D2 WNK1 CIC PHLDB1 COL4A6 OGFR EML3 MYH14	1.49e-05	199	207	10	3987_UP
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A	SETX EPS8L1 CASZ1 MAPK8IP3 CACTIN HDAC5 MINK1 SMC4 RGS14 MYH14	1.49e-05	199	207	10	2402_DN
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A	ATXN2L RIN3 EPS8L1 WNK1 MAPK8IP3 PHLDB1 AP1B1 VAMP2 OGFR MINK1	1.49e-05	199	207	10	3543_DN
Drug	Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RIN3 ABCA2 CEL KCND3 VAMP2 OGFR MINK1 APLP1 HIVEP3 MAPK8IP2	1.49e-05	199	207	10	4119_DN
Drug	Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A	EPS8L1 WNK1 USP19 CACTIN AMH SMC4 AMBRA1 SEZ6L2 PIGQ MAPKBP1	1.49e-05	199	207	10	5988_DN
Drug	valdecoxib; Up 200; 10uM; PC3; HT_HG-U133A	WNK1 CASZ1 MAPK8IP3 BMP6 CACNA1I SLC4A3 RGS3 KHDRBS1 MYH14 ELF4	1.56e-05	200	207	10	6408_UP
Drug	Thonzonium bromide [553-08-2]; Down 200; 6.8uM; HL60; HT_HG-U133A	LILRB2 DENND1C MAPK8IP3 URB1 WIZ VAMP2 OGFR EML3 RGS14 MAPKBP1	1.56e-05	200	207	10	3080_DN
Drug	covellite	CUX2 HGS CUX1	2.52e-05	7	207	3	CID000014831
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A	ZSWIM8 ABCA2 EPS8L1 BCL9 CACTIN PHLDB1 BAHCC1 MINK1 TNS2	6.09e-05	189	207	9	5208_DN
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	ATXN2L RIN3 ABCA2 MAPK8IP3 WIZ BAHCC1 OGFR MINK1 EML3	6.34e-05	190	207	9	4340_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	KMT2B CEL NOL6 WNK1 URB1 PHLDB1 CASKIN2 MINK1 MAPK8IP2	6.34e-05	190	207	9	4582_DN
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	C15orf39 TSC22D2 BCL9 CASKIN2 OGFR MINK1 DUSP8 ELF4 SLC16A10	6.60e-05	191	207	9	5210_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	ATXN2L INPPL1 C15orf39 CACTIN BMP6 CASKIN2 BAHCC1 DUSP8 TNS2	6.60e-05	191	207	9	5204_DN
Drug	Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; HL60; HT_HG-U133A	DENND1C MAPK8IP3 CACTIN EHBP1L1 DUSP8 AMBRA1 NPDC1 RGS14 CUX1	6.87e-05	192	207	9	1286_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	WBP2 CIC CASKIN2 BAHCC1 HSPG2 AMBRA1 SEZ6L2 RGS14 SLC16A2	7.15e-05	193	207	9	3262_UP
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A	WBP2 WIZ AP1B1 CASKIN2 TMEM259 ZNF358 PLXNB1 OGFR UBXN1	7.44e-05	194	207	9	4331_DN
Drug	Iopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A	KMT2B LRFN3 CACTIN PHLDB1 TMEM259 BAHCC1 OGFR PIGQ ELF4	7.44e-05	194	207	9	3527_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	EPS8L1 CACTIN PHLDB1 EHBP1L1 WIZ NBEAL2 HSPG2 EML3 MAPK8IP2	7.44e-05	194	207	9	4804_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A	GMIP PHF1 WIZ TMEM259 ZNF358 VAMP2 HSPG2 MINK1 RGS14	7.44e-05	194	207	9	4242_DN
Drug	Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; HL60; HT_HG-U133A	CIC CACTIN NBEAL2 FMNL1 HSPG2 RANGAP1 DUSP8 RGS3 MAPKBP1	7.74e-05	195	207	9	1293_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; HL60; HT_HG-U133A	IL16 TBC1D2B EPS8L1 VAMP2 DIAPH1 BAHCC1 OGFR NPDC1 MYH14	7.74e-05	195	207	9	2409_DN
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	TBC1D2B URB1 CASKIN2 TMEM259 BAHCC1 TNS2 HIVEP3 RGS14 ELF4	7.74e-05	195	207	9	2230_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	GMIP BCL9 WNK1 CIC PHLDB1 NBEAL2 VAMP2 PLXNB1 FRAT1	7.74e-05	195	207	9	1665_DN
Drug	Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A	WIZ CASKIN2 TMEM259 VAMP2 PLXNB1 BAHCC1 RANGAP1 PIGQ HIVEP3	7.74e-05	195	207	9	2264_DN
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A	ABCA2 KMT2B LILRB2 EPS8L1 CASKIN2 BAHCC1 SMC4 PIGQ MAPKBP1	8.05e-05	196	207	9	6846_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A	NOL6 TBC1D2B WNK1 CASKIN2 BAHCC1 COL4A6 HSPG2 UBXN1 HIVEP3	8.05e-05	196	207	9	4292_DN
Drug	Cefaclor [70356-03-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A	C15orf39 BCL9 CASKIN2 VAMP2 SLC52A1 MINK1 EML3 PIGQ SLC16A2	8.05e-05	196	207	9	2843_UP
Drug	Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A	CIC CASZ1 MAPK8IP3 KCND3 CACNA1I FMNL1 CTC1 DUSP8 RGS14	8.05e-05	196	207	9	3144_UP
Drug	Carisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	EPS8L1 USP19 CACTIN CASKIN2 ZNF358 RANGAP1 OGFR AMBRA1 UBXN1	8.05e-05	196	207	9	6610_DN
Drug	Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A	C15orf39 CASZ1 CACTIN WIZ AP1B1 CASKIN2 TMEM259 OGFR ELF4	8.05e-05	196	207	9	3471_DN
Drug	Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; PC3; HT_HG-U133A	URB1 PHLDB1 NBEAL2 VAMP2 MINK1 DUSP8 AMBRA1 RGS14 ELF4	8.05e-05	196	207	9	7278_DN
Drug	Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HT_HG-U133A	NOL6 CASZ1 ZNF358 VAMP2 BAHCC1 MINK1 UBXN1 SLC4A3 MYH14	8.05e-05	196	207	9	4591_DN
Drug	PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A	CEL LRFN3 EPS8L1 MAPK8IP3 BMP6 PHLDB1 AMBRA1 UBXN1 ZFHX2	8.05e-05	196	207	9	6591_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	KMT2B USP19 VAMP2 HSPG2 DUSP8 UBXN1 RGS3 ZFHX2 ELF4	8.05e-05	196	207	9	2889_DN
Drug	Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A	KMT2B EPS8L1 CHRNA10 BAHCC1 TBX5 CTC1 MINK1 SMC4 HIVEP3	8.37e-05	197	207	9	1528_UP
Drug	Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	KMT2B MEOX2 NRXN2 VAMP2 TBX5 COL4A6 NIBAN1 MINK1 RGS14	8.37e-05	197	207	9	3191_UP
Drug	Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A	ZSWIM8 WNK1 WIZ CHRNA10 SLC52A1 OGFR MINK1 RGS14 BICDL1	8.37e-05	197	207	9	6779_UP
Disease	Global developmental delay	MAPK8IP3 AP1B1 VAMP2 DIAPH1 MN1 TET3 TCF20 PIGQ	3.68e-06	133	200	8	C0557874
Disease	Intellectual Disability	CIC MAPK8IP3 KMT2C AP1B1 NRXN2 VAMP2 DIAPH1 MN1 TET3 CUX2 TCF20 PTPN23 SHANK3	1.27e-05	447	200	13	C3714756
Disease	Autistic behavior	VAMP2 TET3 CUX2	1.68e-05	8	200	3	C0856975
Disease	PR interval	EMILIN2 TSC22D2 DNAAF3 ZNF469 KCND3 CASKIN2 ZNF358 TBX5 HSPG2 MINK1 HIVEP3 CD93 ARHGEF40	3.66e-05	495	200	13	EFO_0004462
Disease	Holt-Oram syndrome	TBX5 SALL4	4.57e-05	2	200	2	C0265264
Disease	Wildervanck's syndrome	TBX5 SALL4	4.57e-05	2	200	2	C0265239
Disease	Kleefstra syndrome 2 (implicated_via_orthology)	KMT2C KMT2D	4.57e-05	2	200	2	DOID:0080598 (implicated_via_orthology)
Disease	Holt-Oram syndrome (is_implicated_in)	TBX5 SALL4	4.57e-05	2	200	2	DOID:0060468 (is_implicated_in)
Disease	maturity-onset diabetes of the young type 1 (implicated_via_orthology)	HNF4A HNF4G	4.57e-05	2	200	2	DOID:0111099 (implicated_via_orthology)
Disease	Phelan-McDermid syndrome (implicated_via_orthology)	TCF20 SHANK3	4.57e-05	2	200	2	DOID:0080354 (implicated_via_orthology)
Disease	Tourette syndrome, schizophrenia	CACNA1I TCF20 SNORC	2.32e-04	18	200	3	EFO_0004895, MONDO_0005090
Disease	Fanconi syndrome (implicated_via_orthology)	HNF4A HNF4G	2.72e-04	4	200	2	DOID:1062 (implicated_via_orthology)
Disease	tenascin-X measurement	DXO TNXB	2.72e-04	4	200	2	EFO_0802121
Disease	Congenital myotonia	CLCN1 HSPG2	2.72e-04	4	200	2	cv:CN295225
Disease	Autism Spectrum Disorders	CIC NRXN2 TET3 SHANK3 SLC16A2	2.88e-04	85	200	5	C1510586
Disease	QT interval	ATXN2L NOL6 CASZ1 TRPM5 PTPRJ ZNF358 TBX5 DXO HDAC5 SLC4A3 YBX2 CUX1	3.09e-04	534	200	12	EFO_0004682
Disease	mean arterial pressure	ZNF831 HNF4G CASZ1 TTBK1 PTPRJ BAHCC1 NIBAN1 CUX2 TCF20 TNS2 HIVEP3	6.42e-04	499	200	11	EFO_0006340
Disease	pseudohypoaldosteronism (implicated_via_orthology)	WNK1 WNK2	6.74e-04	6	200	2	DOID:4479 (implicated_via_orthology)
Disease	Nephronophthisis, familial juvenile	ANKS6 MAPKBP1	9.39e-04	7	200	2	C1855681
Disease	Colorectal Carcinoma	SALL3 WNK1 KMT2C BMP6 KCND3 KLF5 UNG COL4A6 AKAP12 HIVEP3 CD93 PRKCZ CUX1	1.07e-03	702	200	13	C0009402
Disease	cardiac arrhythmia	KCND3 TBX5 CUX2	1.09e-03	30	200	3	EFO_0004269
Disease	venous thromboembolism, fibrinogen measurement	ATXN2L HNF4A PTPRJ SHANK3	1.12e-03	67	200	4	EFO_0004286, EFO_0004623
Disease	interferon-induced protein with tetratricopeptide repeats 3 measurement	CEL SMIM33	1.25e-03	8	200	2	EFO_0801710
Disease	coronary artery disease	WBP2 CEL ZNF831 MAPK8IP3 PHF1 DNAAF3 CRACD EHBP1L1 AFAP1L2 PTPRJ ZC3H12D WNK2 DXO CUX2 AKAP12 MALRD1 ADAMTS7 TNXB	1.35e-03	1194	200	18	EFO_0001645
Disease	JT interval	ATXN2L CASZ1 KCND3 DXO HDAC5 SLC4A3 CUX1	1.58e-03	248	200	7	EFO_0007885
Disease	interleukin 18 receptor accessory protein measurement	DXO TNXB	1.59e-03	9	200	2	EFO_0008179
Disease	Abnormality of the face	MN1 TET3	1.59e-03	9	200	2	C4025871
Disease	esophagus squamous cell carcinoma (is_marker_for)	BMP6 TET3 KMT2D SLC16A10	1.63e-03	74	200	4	DOID:3748 (is_marker_for)
Disease	maturity-onset diabetes of the young (implicated_via_orthology)	HNF4A HNF4G	1.98e-03	10	200	2	DOID:0050524 (implicated_via_orthology)
Disease	visceral heterotaxy (implicated_via_orthology)	ANKS6 DNAAF3 AP1B1	2.01e-03	37	200	3	DOID:0050545 (implicated_via_orthology)
Disease	Developmental delay (disorder)	DIAPH1 TCF20 PIGQ	2.01e-03	37	200	3	C0424605
Disease	bitter alcoholic beverage consumption measurement	CIC NRXN2 TET3 BAHCC1 SEZ6L2	2.17e-03	133	200	5	EFO_0010092
Disease	Congenital small ears	SF3B4 KMT2D SIX5	2.71e-03	41	200	3	C0152423
Disease	Bladder Neoplasm	TSC1 KMT2C GLI1 KLF5 KMT2D	2.71e-03	140	200	5	C0005695
Disease	Malignant neoplasm of urinary bladder	TSC1 KMT2C GLI1 KLF5 KMT2D	2.80e-03	141	200	5	C0005684
Disease	Dental enamel hypoplasia	DHX37 MYH14	2.89e-03	12	200	2	EFO_1001304
Disease	psoriatic arthritis	CEL BAG6 TNXB SLC16A10	2.94e-03	87	200	4	EFO_0003778
Disease	urate measurement	HNF4A HNF4G MEN1 NRXN2 GLI1 ALDH16A1 CUX2 SLC52A1 HDAC5 ARHGAP17 POLR3C RGS14 MALRD1 SLC16A10	3.30e-03	895	200	14	EFO_0004531
Disease	hematologic cancer (implicated_via_orthology)	CUX2 CUX1	3.39e-03	13	200	2	DOID:2531 (implicated_via_orthology)
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	WBP2 TMEM132E	3.39e-03	13	200	2	C1846647
Disease	Skin Abnormalities	ZNF469 AP1B1	3.39e-03	13	200	2	C0037268
Disease	sleep duration	ARRDC1 DNAAF3 PTPRJ CTC1 MINK1 TMEM132E STON2 ADAMTS14	3.42e-03	362	200	8	EFO_0005271
Disease	autism spectrum disorder (implicated_via_orthology)	TSC1 NRXN2 TCF20 SHANK3 PIANP	3.85e-03	152	200	5	DOID:0060041 (implicated_via_orthology)
Disease	cortical thickness	VWA5B2 RIN3 KMT2B TSC22D2 HNF4G MAPK8IP3 DNAAF3 BMP6 ZNF469 PHLDB1 WNK2 HSPG2 ARHGEF40 MALRD1 ADAMTS7 PRKCZ	3.93e-03	1113	200	16	EFO_0004840
Disease	Kartagener syndrome (implicated_via_orthology)	DNAAF3 AP1B1	3.94e-03	14	200	2	DOID:0050144 (implicated_via_orthology)
Disease	Maturity onset diabetes mellitus in young	CEL HNF4A	3.94e-03	14	200	2	C0342276
Disease	early cardiac repolarization measurement	KCND3 PDZD8	3.94e-03	14	200	2	EFO_0004885
Disease	Squamous cell carcinoma of esophagus	KMT2C SALL4 KMT2D TNXB	4.03e-03	95	200	4	C0279626
Disease	Paroxysmal atrial fibrillation	BEST3 CASZ1 KCND3 TBX5 HSPG2	4.30e-03	156	200	5	C0235480
Disease	familial atrial fibrillation	BEST3 CASZ1 KCND3 TBX5 HSPG2	4.30e-03	156	200	5	C3468561
Disease	Persistent atrial fibrillation	BEST3 CASZ1 KCND3 TBX5 HSPG2	4.30e-03	156	200	5	C2585653
Disease	P wave duration	KCND3 TBX5	4.53e-03	15	200	2	EFO_0005094
Disease	Atrial Fibrillation	BEST3 CASZ1 KCND3 TBX5 HSPG2	4.79e-03	160	200	5	C0004238
Disease	hypertension	ZNF831 CASZ1 TTBK1 PTPRJ BAG6 CUX2 TNXB	5.13e-03	307	200	7	EFO_0000537
Disease	Congenital total cataract	FYCO1 NHS	5.15e-03	16	200	2	C0266539
Disease	intracerebral hemorrhage	DNAAF3 CUX2	5.15e-03	16	200	2	EFO_0005669
Disease	preeclampsia, hypertension, pregnancy-induced	ZNF831 TNS2	5.15e-03	16	200	2	EFO_0000668, MONDO_0024664
Disease	tyrosine measurement	HNF4A PRAG1 TTBK1 SLC16A10	5.56e-03	104	200	4	EFO_0005058
Disease	MAJOR AFFECTIVE DISORDER 2	CUX2 PRKCZ	5.81e-03	17	200	2	C1839839
Disease	risk-taking behaviour	ADGRB1 DNAAF3 TTBK1 TET3 BAHCC1 RANGAP1 ABI1 TCF20 RGS3 HIVEP3 PRKCZ TNXB	6.16e-03	764	200	12	EFO_0008579
Disease	eosinophil count	RIN3 CEL GMIP WNK1 NACAD PTPRJ ZC3H12D TET3 BAHCC1 DXO CUX2 CARMIL2 FRAT1 SMC4 HIVEP3 RGS14 TNKS1BP1 TNXB CUX1	6.18e-03	1488	200	19	EFO_0004842
Disease	Ischemic stroke, fibrinogen measurement	ATXN2L HNF4A SHANK3	6.21e-03	55	200	3	EFO_0004623, HP_0002140
Disease	Diffuse Large B-Cell Lymphoma	GLI1 RANGAP1 KMT2D	6.21e-03	55	200	3	C0079744
Disease	testosterone measurement	ATXN2L BCL7C TSC22D2 HNF4A BMP6 URB1 TTBK1 PTPRJ HS3ST4 KISS1 DXO CUX2 ZBTB4 RGS14 ARHGEF40 LIPE TNKS1BP1	6.27e-03	1275	200	17	EFO_0004908
Disease	neutrophil count	TRNP1 RIN3 CEL BCL9 HNF4A CIC CASZ1 VSIR PTPRJ KCND3 KLF5 NBEAL2 CUX2 FRAT1 PLEKHG2 AKAP12 HIVEP3 TNXB	6.28e-03	1382	200	18	EFO_0004833
Disease	C-X-C motif chemokine 16 measurement	FYCO1 VSIR	6.51e-03	18	200	2	EFO_0010911
Disease	Nuclear non-senile cataract	FYCO1 NHS	6.51e-03	18	200	2	C1112705
Disease	Nuclear cataract	FYCO1 NHS	6.51e-03	18	200	2	C0392557
Disease	corneal topography	ZNF469 FRAT1 ADAMTS7 STON2	6.55e-03	109	200	4	EFO_0004345
Disease	Malignant neoplasm of breast	TTC3 WNK1 CIC CLCN1 GLI1 NHS RIC8A PLXNB1 ZNF541 MAGEE1 AKAP12 FOXP4 KMT2D LIPE CUX1	6.70e-03	1074	200	15	C0006142

Protein segments in the cluster

Peptide	Gene	Start	Entry
APAGQEEPGTPPSSP	UNG	51	P13051
EGGPPAPPPNLTSNR	VAMP2	16	P63027
KQPGSPSPPSIPETG	ZNF385A	156	Q96PM9
SPSEKETPPGGPSPQ	BEST3	551	Q8N1M1
RPPELSPSPQSPEGG	CHRNA10	361	Q9GZZ6
EPNGSALPPTEGPPS	SLC4A3	871	P48751
LGDLPSDSPPDPQPP	BAHCC1	1301	Q9P281
GPPGPPSPEFETETL	COL4A6	436	Q14031
TGPEGPLSDTPTPPL	ARHGEF40	486	Q8TER5
QEPEPAPGTPGLSGP	ANKLE1	146	Q8NAG6
TPSTPQTDPTGPEGP	CTC1	711	Q2NKJ3
NEATGPGFIPPPLAP	CTAGE6	686	Q86UF2
NEATGPGFIPPPLAP	CTAGE8	686	P0CG41
NEATGPGFIPPPLAP	CTAGE15	686	A4D2H0
PSTLPAGPEIGPSPA	ALDH16A1	511	Q8IZ83
QNPELTPGPAPAGPT	BAG6	246	P46379
EAPPPGPGQASSVAP	BAG6	401	P46379
NLEPAPPSLGDPGEP	ADGRB1	1431	O14514
ASVPSAPSAPGPGPE	CASZ1	401	Q86V15
GPGPEPPASLSFNTP	CASZ1	411	Q86V15
SPEQPPEGSSTPAEP	AKAP12	11	Q02952
EQTEPPPSGTPGPDD	CUX1	1371	P39880
LQGDPGTPSGTPEPP	DUSP8	306	Q13202
GLGTEPLPPQPTEPS	CARMIL2	1401	Q6F5E8
ALPADSGPGPTPDEP	AFAP1L2	571	Q8N4X5
VEPVPAPGADSPPGT	CDRT15P3	31	P0DPF6
PVSLGPPSGPPDEED	CD93	471	Q9NPY3
PPPGTPDPSGTAVGD	APLP1	211	P51693
IGPENISVPPPSGAP	ABI1	271	Q8IZP0
PETAPTGAPPGEQPD	AP1B1	606	Q10567
PGTPGREPTQPTLPS	AMBRA1	1236	Q9C0C7
PPSTDVPPSPEAGGT	CDHR5	456	Q9HBB8
DSGTIIPPPPAPGDS	DIAPH1	591	O60610
PLPEGVGIPSPSSLP	DIAPH1	656	O60610
PPTGDSEATPVPPTG	CEL	561	P19835
PTGDSGAPPVPPTGD	CEL	606	P19835
PTGDSGAPPVPPTGD	CEL	661	P19835
TAPVPPTGDSGAPPV	CEL	711	P19835
PTGDSGAPPVPPTGD	CEL	716	P19835
PPTGDSEAAPVPPTD	CEL	726	P19835
PEDPLSPSPGQPLLG	CUX2	451	O14529
TSEPPGAGTPPLSPE	DENND1C	521	Q8IV53
GAGPQPPPSQDPELL	BICDL1	86	Q6ZP65
SVPGAPEPCPQDGSP	ARRDC1	351	Q8N5I2
TPGSPLPGPQDPADA	ADAMTS14	1116	Q8WXS8
QAGRSPPPPSEQTPG	ADAMTS7	1136	Q9UKP4
PLAPSGGTEGPEQPP	ATXN2L	611	Q8WWM7
DPDPNGELLPGSPNP	SLC16A2	521	P36021
DPNTGEPAPVLSSPP	RANGAP1	416	P46060
PTTFGPTGVPAPIPV	OTUD4	601	Q01804
EPSSPGPIPAPGLAQ	HSPG2	2911	P98160
SATSEGSPPGPDAPP	RGS3	746	P49796
EPPVPEAPSSGPPSS	PTPN23	1561	Q9H3S7
LTFQPSPAPDPPGGL	MEN1	61	O00255
TGITDPPPPDGSPNI	PTPRJ	811	Q12913
EGESRPPPASPGPNT	KCND3	626	Q9UK17
PDTPESPGPPSVQPT	MAP3K10	916	Q02779
LSPGPGPSQAVPLPE	FAM156A	46	Q8NDB6
GPPSFVPDSPSIPVG	KMT2C	3511	Q8NEZ4
PTPGEGPSTSVLPIP	MAGEE1	346	Q9HCI5
DPAPTPSSGPQPGSE	MAPK8IP3	926	Q9UPT6
PSSGPQPGSENGPEP	MAPK8IP3	931	Q9UPT6
LPPTSEKSPSPGGPQ	NCKAP5L	461	Q9HCH0
TPLVPGPTDPSQGPE	NCKAP5L	861	Q9HCH0
PTNPAPPTVTGAGPA	ELF4	496	Q99607
TEPPPQDSSPAPGPL	GMIP	766	Q9P107
QGEPSPALSPASPGP	FYCO1	1246	Q9BQS8
TTGAPEPPPLSGAPQ	GINM1	26	Q9NU53
PAEPPAPGGTSPSSD	MAPK8IP2	211	Q13387
LGPVSTGPPPVNKPE	FAM90A27P	161	A6NNH2
QAATPETPQPSPPGG	HNF4A	426	P41235
ETPQPSPPGGSGSEP	HNF4A	431	P41235
AQPGSGPSPEPEGSP	MYH14	1976	Q7Z406
QSPLVSPDPPARGGP	PLXNB1	676	O43157
GGATPTAAPETPAPP	PDZD8	76	Q8NEN9
DPLALGPESPGEPQP	FKBP15	1106	Q5T1M5
DPGVSESPPPGRQPN	IL16	916	Q14005
ENPPLGPGAPTSFEP	NRXN2	1576	Q9P2S2
GQSPAGDGSPEPPTP	NOL6	281	Q9H6R4
PSVNGEPGSVPPPRA	EHBP1L1	1256	Q8N3D4
GSSPSEEPPPSPGEE	EHBP1L1	1336	Q8N3D4
LSPPPESSGSPQQPG	KISS1	71	Q15726
SPPPTGPISTPGPED	LILRB2	426	Q8N423
GPISTPGPEDQPLTP	LILRB2	431	Q8N423
PGPEDQPLTPTGSDP	LILRB2	436	Q8N423
LASPFPPGSPPENGA	GLI1	561	P08151
QQPPSPGSPEGPRSL	GABRE	426	P78334
EDRQPGPPLGAPNPS	FOXP4	646	Q8IVH2
QEPETPESGQPPGDP	KMT2B	1546	Q9UMN6
LTPTSGELAPPGPAP	KMT2B	1951	Q9UMN6
EPTPSLRFQEPPPGG	AMH	141	P03971
TNGALGPTPTPAPPA	LRFN3	586	Q9BTN0
QPDSGGPPELGSSPP	MEOX2	111	P50222
PRAPSAPQLPESGPG	LBX2	26	Q6XYB7
APQLPESGPGPTSPL	LBX2	31	Q6XYB7
TPLEPATASPVPPGG	GOLGA3	1461	Q08378
APQPSGGDPSPPQER	CASKIN2	716	Q8WXE0
TPGESPPASSLPQPE	CASKIN2	1026	Q8WXE0
SPPPTNGPGPNFDLR	DXO	71	O77932
PETPLPSPPQGSGQE	HNF4G	371	Q14541
PTEGSVPPPLSSSPG	SMPD4	236	Q9NXE4
ELGLPSTPGTPTPTP	NPDC1	141	Q9NQX5
NPPLGPGAPTSFEPR	NRXN2	531	P58401
EGPTPPGPSVTATAP	POM121	741	Q96HA1
PGNLPADLPTPPETS	MALRD1	1026	Q5VYJ5
GPPPGTVLEPQSAPE	RGL4	181	Q8IZJ4
PQDISEPPGGSPLPS	C6orf132	151	Q5T0Z8
SIPSSEGASPEPPPP	CEFIP	1311	Q711Q0
TEPSPGGTPQPSRPV	BCL7C	111	Q8WUZ0
SPAGPPEGVPEEAQP	BCL7C	126	Q8WUZ0
EGSPEPGTPAAPTPE	DNAAF3	341	Q8N9W5
TAPLSGEPQGPPSQP	DMRTC2	236	Q8IXT2
TPLPPDGTGPNSTPN	BCL9	296	O00512
ESGGPPPPTASQPAS	BCL9	966	O00512
PPSSPPGLEEPLDGA	CACNA1I	31	Q9P0X4
LGPSEETAPQPPPAG	CRACD	751	Q6ZU35
DGGSPGRTEQPPPSP	BMP6	46	P22004
EPGGPQEPGLASSPP	ABCA2	1226	Q9BZC7
GPAPGSSPSELPASP	ANKS6	691	Q68DC2
QAPPLGPGTPTALPD	TMEM259	466	Q4ZIN3
GANPPGAPPEVEPSS	MAPKBP1	1141	O60336
GAPPEVEPSSGNPSP	MAPKBP1	1146	O60336
APTPGVPTGSPSPDL	FMNL1	516	O95466
SPLPPQADLDGPPGA	FRAT1	141	Q92837
ATVGGPAPTPLLPPS	KHDRBS1	76	Q07666
PEDAAPTPPGPSSEG	CACTIN	496	Q8WUQ7
PTPPGPSSEGGPAEA	CACTIN	501	Q8WUQ7
SGTPAPPGDSLAAPP	EML3	56	Q32P44
PEERPPQPPGSTGVI	EMILIN2	831	Q9BXX0
PGPGSPLDPASTTAP	FCRLB	286	Q6BAA4
LDQSSPPQSGPPGTP	HDAC5	221	Q9UQL6
PGPRAPEPQLSPGSD	EPS8L1	621	Q8TE68
GVGTTVAPLPPAPAP	DHX37	191	Q8IY37
GSSSPPPARGVQPPE	PWWP2B	81	Q6NUJ5
TPGGPAEPSAPAAPS	SALL3	301	Q9BXA9
DLQPGPSPESEGGPT	SALL4	506	Q9UJQ4
QESPGAAAEPPPSPP	HS3ST4	66	Q9Y661
PAPTPEPGNAELEPT	MFAP2	76	P55001
EEPEVIPGPPSESPG	PRPF3	121	O43395
PGPGEPPPAQQEAES	LIPE	141	Q05469
ETPTPGPPREGQSPA	RIN3	491	Q8TB24
SDPTSEGPGPSPNPP	MINK1	641	Q8N4C8
ESPSETPGPSPAGPT	OGFR	576	Q9NZT2
ESPSETPGPSPAGPT	OGFR	636	Q9NZT2
PPNPPAQGDGTSLSP	MN1	906	Q10571
PPPVEPPTGDGALTS	PHF1	336	O43189
ELQEGPLSTPPPPGD	RUSC1	31	Q9BVN2
TPPTSLPEPFSGDPG	RTL6	96	Q6ICC9
GSPSPPPGTSLDNPV	RAB11FIP1	1081	Q6WKZ4
ELGPAAAGSAPPPTP	SCRT1	76	Q9BWW7
TPAGQSVAPGPFPPV	SSPOP	2376	A2VEC9
APEAPGPGTASPVVP	TMEM132E	851	Q6IEE7
PPPPPVGGAVAQSSA	TSC22D2	276	O75157
GVSGPSQDLLPPPNP	TBX5	296	Q99593
DASGGSAEPPPPLQP	NHS	26	Q6T4R5
PLPPTDGSTVVPAGP	ARHGAP17	526	Q68EM7
DGSTVVPAGPEPPPQ	ARHGAP17	531	Q68EM7
PPATPSGFEEGPPSS	PIANP	86	Q8IYJ0
TPASQPGTPSPLDGP	NBEAL2	1381	Q6ZNJ1
SLTPVPSGPGPSLPE	PIGQ	731	Q9BRB3
VLGPQDSPEEAPPGP	SMIM33	96	A0A1B0GW64
DSPEEAPPGPLVPGS	SMIM33	101	A0A1B0GW64
DEESGGTLPPPDFPP	INPPL1	1041	O15357
SPGVPGSPPEAASEP	SIX5	66	Q8N196
GAPPPQPSPQGASET	SIX5	366	Q8N196
SSPQHPGATPPTGEP	SETX	2561	Q7Z333
PEPGPPDPAGLLSQT	SETD1B	596	Q9UPS6
EDGPPTVAPGPVQSP	WIZ	1296	O95785
GPTAPELLTPPPGTT	SEZ6L2	116	Q6UXD5
PSASPGPPGPALTSD	SSC5D	1011	A1L4H1
PATPDAPPTTGDPGA	PMIS2	16	A0A1W2PS18
GVTPEGNPPPTLLPS	RIC8A	201	Q9NPQ8
PGPDPTQEPVDSASP	URB1	2071	O60287
AASPPGSPEQPPPDL	STON2	81	Q8WXE9
QGLENRGEPPTPPSP	CIC	1281	Q96RK0
PSPAGGPDPTSPSSD	CIC	1551	Q96RK0
TAPLSPEEPNGPLPG	CLCN1	736	P35523
APTQPAPTPTSGPIG	C15orf39	676	Q6ZRI6
QVDPGATGPLPPSSP	TMEM268	6	Q5VZI3
PGNPATAVSGTPAPP	YBX2	66	Q9Y2T7
LGSAETPPPVPAPGS	TRIM24	96	O15164
AVPTGPTPLDSTPPG	USP19	396	O94966
DGPHPSPPTPDSVGQ	TSC1	1136	Q92574
VPPARAQPDGTPSPG	TTBK1	1276	Q5TCY1
PPGSPPVSATAAGPE	ZBP1	286	Q9H171
AGTTDPVPGPPTEPL	ZFHX2	2291	Q9C0A1
PSVPTTENSDPGPPP	POLR3C	161	Q9BUI4
TENSDPGPPPPAPTL	POLR3C	166	Q9BUI4
DFRPPPQGPSGPEVT	TRPM5	756	Q9NZQ8
SLPGPSPPPDGTEQV	NIBAN1	641	Q9BZQ8
PPSQAAGTIPGPDPE	SLC52A1	256	Q9NWF4
LPSPRAQPPGGTPAD	SHANK3	1251	Q9BYB0
PPGDLGLPTEPQDTP	SOWAHA	131	Q2M3V2
PQDTPGGPASEPAQP	SOWAHA	141	Q2M3V2
EGGSETVALPPPPPS	TSPYL1	51	Q9H0U9
TVALPPPPPSEEGGV	TSPYL1	56	Q9H0U9
PPPPSEEGGVPQDAA	TSPYL1	61	Q9H0U9
EPSTPLSPPGPGDVF	VSIR	281	Q9H7M9
PPLPPSTAAPVGQGA	WASH2P	321	Q6VEQ5
TPSPGLPAEGAPEAP	TNKS1BP1	351	Q9C0C2
TPSPTEPGTEAPGPP	TNXB	2506	P22105
PPLPPSTAAPVGQGA	WASHC1	321	A8K0Z3
LPETDSQPIPPSGGP	HGS	376	O14964
SQPIPPSGGPFSEPQ	HGS	381	O14964
GPGTPESSVTPPEFP	PRO2289	26	Q9P1D8
PILGPQPPDAPASGT	HIVEP3	1896	Q5T1R4
AGTPVPGTPTSEPAP	ZNF395	341	Q9H8N7
DSPGEAPSALLPGPP	TTC3	1781	P53804
PLPPATGGAAPNPAT	ZBTB4	66	Q9P1Z0
VGPQPTPSIPGAPAT	PRRT4	21	C9JH25
EGPPPPSPDGASSDA	SMC4	16	Q9NTJ3
TGPPAPTVAPGPEDS	SNORC	61	Q6UX34
LPSGPSSPFPTEEQP	RGS14	46	O43566
TPPPEEQGQGDAPPQ	USP9Y	46	O00507
SPSGQEPGPSVPPLV	PHLDB1	271	Q86UU1
PQPPQIPEGSADGEP	TCF20	1561	Q9UGU0
SFGLPGPPSVPIQDP	TET3	721	O43151
SSIGPQPPSQGPADP	PRAG1	581	Q86YV5
GSVGSQPPPVAPEPG	UBXN1	181	Q04323
APEPGPVPSSPSQEP	UBXN1	191	Q04323
LSGTQDPFPGPAPVP	WDR46	91	O15213
PFTGADGQPAIPPPL	WASF2	406	Q9Y6W5
SQFSPGDLPPPPGLQ	ZC3H12D	396	A2A288
PTEPPTLQGAGPDSP	ZNF469	2321	Q96JG9
SEGPEPPTASVGPPG	ZSWIM8	676	A7E2V4
PSPLVSGGFPPPEEE	ZSWIM8	1636	A7E2V4
GPGSPEGSAPLEPPS	VWA5B2	691	Q8N398
PGDGSQPPSPPVREA	VWA5B2	866	Q8N398
PPESQPPVSGSAPPE	PLEKHG2	511	Q9H7P9
GTLPSEQLPPFPGPS	WNK1	1771	Q9H4A3
PEPVGTQEPGPDPIA	WNK2	116	Q9Y3S1
PPQPPSALESDGEGP	WNK2	1561	Q9Y3S1
STSSLAPGPEPGPQP	WNK2	2126	Q9Y3S1
PEPVSAETPGGPTQP	ZNF831	836	Q5JPB2
PPGNAPEDPSSGPLV	ZNF831	1106	Q5JPB2
GGDPLPQPSGTPTPS	TMUB1	36	Q9BVT8
PTPGQSPPLPDAAGA	TRNP1	46	Q6NT89
EGNGPPPTVAPSSPS	TBC1D2B	461	Q9UPU7
PPSSPSSQEPGSGQP	UBQLN3	381	Q9H347
PNPVVSSLGSGLPPP	SF3B4	221	Q15427
GPSQPSDPGVLELPP	SIGLEC11	411	Q96RL6
PSGSGPEPLAPSPVS	TNS2	961	Q63HR2
PSSGSPSEESPPGPG	ZNF541	451	Q9H0D2
NPDPGSGPGTLPDPS	ZNF358	461	Q9NW07
EEAGSPTLPQGPPVP	PSORS1C2	36	Q9UIG4
PPVSGPDVPSTPAAE	WBP2	206	Q969T9
PPSPPSSEPGSPDRQ	KLF5	301	Q13887
EAQPLGPAPTGAAPP	SLC16A10	16	Q8TF71
GEPALSEPGEPPLSP	KMT2D	896	O14686
FPSTPEQPGLPCPGE	PRKCZ	96	Q05513
DEEPPGSLGLPPPQA	NACAD	1261	O15069